<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Market News &#38; Stocks to Watch from StraightStocks &#187; Michael Vlaicu</title>
	<atom:link href="http://www.straightstocks.com/author/michaelvlaicu/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.straightstocks.com</link>
	<description>Leading Stock Market News, Opinions and Commentary</description>
	<lastBuildDate>Thu, 26 Nov 2009 10:32:19 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.5</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Technical Breakout Alert Issued for CytRx (NASDAQ:CYTR)</title>
		<link>http://www.straightstocks.com/stock-watch/technical-breakout-alert-issued-for-cytrx-nasdaqcytr/</link>
		<comments>http://www.straightstocks.com/stock-watch/technical-breakout-alert-issued-for-cytrx-nasdaqcytr/#comments</comments>
		<pubDate>Mon, 23 Nov 2009 13:35:02 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[2 protocol]]></category>
		<category><![CDATA[Acute Myeloid Leukemia]]></category>
		<category><![CDATA[Alexion Pharmaceuticals Inc;]]></category>
		<category><![CDATA[Am-80]]></category>
		<category><![CDATA[Amgen Inc.]]></category>
		<category><![CDATA[APL]]></category>
		<category><![CDATA[bone marrow transplant]]></category>
		<category><![CDATA[Breast Cancer]]></category>
		<category><![CDATA[breast cancers]]></category>
		<category><![CDATA[Celsion Corporation]]></category>
		<category><![CDATA[Chairman]]></category>
		<category><![CDATA[chairman and CEO]]></category>
		<category><![CDATA[Chief Medical Officer]]></category>
		<category><![CDATA[chief scientific officer]]></category>
		<category><![CDATA[chronic myeloid leukemia]]></category>
		<category><![CDATA[CytRx Corporation]]></category>
		<category><![CDATA[Daniel Levitt]]></category>
		<category><![CDATA[director]]></category>
		<category><![CDATA[director of clinical oncology]]></category>
		<category><![CDATA[Discovery Laboratories Inc;]]></category>
		<category><![CDATA[drug development]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[European Medicines Agency]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[head]]></category>
		<category><![CDATA[Head of Oncology]]></category>
		<category><![CDATA[Hepatocellular carcinoma;]]></category>
		<category><![CDATA[INNO-406]]></category>
		<category><![CDATA[Jack R. Barber]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[Joseph Rubinfeld]]></category>
		<category><![CDATA[leukemia]]></category>
		<category><![CDATA[leukemias]]></category>
		<category><![CDATA[lung cancers]]></category>
		<category><![CDATA[Max Link]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[MiV Investments Inc.]]></category>
		<category><![CDATA[multiple myeloma]]></category>
		<category><![CDATA[myelodysplastic syndrome;]]></category>
		<category><![CDATA[myelodysplastic syndromes]]></category>
		<category><![CDATA[one of the four initial founders]]></category>
		<category><![CDATA[ovarian cancer]]></category>
		<category><![CDATA[Pancreatic Cancer]]></category>
		<category><![CDATA[Philadelphia]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[Protein Design Labs]]></category>
		<category><![CDATA[Sandoz Pharma]]></category>
		<category><![CDATA[Sandoz Pharmaceuticals]]></category>
		<category><![CDATA[sarcoma]]></category>
		<category><![CDATA[STAR-1]]></category>
		<category><![CDATA[The star]]></category>
		<category><![CDATA[treatment for patients with Chronic Myeloid Leukemia]]></category>
		<category><![CDATA[tumor]]></category>
		<category><![CDATA[tumors]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[who served as president]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=827</guid>
		<description><![CDATA[Miv Investments Inc. has initiated an independent bullish technical trading alert for 11/23/09 on CytRx Corporation (NASDAQ:CYTR). Shares of the company finished trading during 11/20/09 at $1.14 per share, up 20.18% from the opening bell on heavy buying pressure. As of 11/18/09, the biopharmaceutical company announced plans to initiate an open-label, multinational Phase 2 clinical [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/technical-breakout-alert-issued-for-cytrx-nasdaqcytr/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Technical Trading Alert for Echo Therapeutics (OTC:ECTE.OB)</title>
		<link>http://www.straightstocks.com/stock-watch/technical-trading-alert-for-echo-therapeutics-otcecte-ob/</link>
		<comments>http://www.straightstocks.com/stock-watch/technical-trading-alert-for-echo-therapeutics-otcecte-ob/#comments</comments>
		<pubDate>Fri, 20 Nov 2009 14:11:14 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=821</guid>
		<description><![CDATA[MivInvestments Inc. has initiated an independent bullish technical trading alert for 11/20/09 on Echo Therapeutics, Inc. (OTC:ECTE.OB). Shares of the company finished the day at $1.35, up 8.15% from the opening bell on heavy buying pressure. The excitement was due to the  announcement on positive results of a clinical study testing symphony(TM) tCGM System [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/technical-trading-alert-for-echo-therapeutics-otcecte-ob/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Power3 Investors Looking Forward to Upcoming Expo (OTC:PWRM.OB)</title>
		<link>http://www.straightstocks.com/stock-watch/power3-investors-looking-forward-to-upcoming-expo-otcpwrm-ob/</link>
		<comments>http://www.straightstocks.com/stock-watch/power3-investors-looking-forward-to-upcoming-expo-otcpwrm-ob/#comments</comments>
		<pubDate>Wed, 18 Nov 2009 06:46:31 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=814</guid>
		<description><![CDATA[Miv Investments Inc. has initiated an independent bullish technical trading alert for 11/18/09 on Power3 Medical Products, Inc. (OTC:PWRM.OB). Shares of the company finished the day at $0.129, up 69.74% from the opening bell on heavy buying pressure. The spark which ignited the rise in share price is being speculated as being attributed due to [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/power3-investors-looking-forward-to-upcoming-expo-otcpwrm-ob/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Bullish Technical Breakout Alert (OTC:SNBP.OB)</title>
		<link>http://www.straightstocks.com/stock-watch/bullish-technical-breakout-alert-otcsnbp-ob/</link>
		<comments>http://www.straightstocks.com/stock-watch/bullish-technical-breakout-alert-otcsnbp-ob/#comments</comments>
		<pubDate>Tue, 17 Nov 2009 12:39:38 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=808</guid>
		<description><![CDATA[Miv Investments Inc. has initiated an independent bullish technical trading alert for 11/17/09 on Sinobiopharma, Inc. (OTC:SNBP.OB). Shares of the company finished the day at $0.25, up 38.89% from the opening bell on heavy buying pressure. The turning point in the share price which had been experiencing a down trend for well over a year, [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/bullish-technical-breakout-alert-otcsnbp-ob/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Bullish Technical Breakout Alert (OTC:SNGX.OB)</title>
		<link>http://www.straightstocks.com/stock-watch/bullish-technical-breakout-alert-otcsngx-ob/</link>
		<comments>http://www.straightstocks.com/stock-watch/bullish-technical-breakout-alert-otcsngx-ob/#comments</comments>
		<pubDate>Wed, 11 Nov 2009 08:50:18 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=798</guid>
		<description><![CDATA[Miv Investments Inc. has initiated an independent bullish technical trading alert for 11/11/09 on Soligenix, Inc. (OTC:SNGX.OB). Shares of the company finished the day at $0.220, up 15.79% from the opening bell on heavy buying pressure. The turning point in the price resulted from two heavy orders of 778,980 at $0.175, and 790,000 at $0.18, [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/bullish-technical-breakout-alert-otcsngx-ob/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Bullish Technical Breakout Alerts (NASDAQ:NCOC), (OTC:BIEL.PK)</title>
		<link>http://www.straightstocks.com/stock-watch/bullish-technical-breakout-alerts-nasdaqncoc-otcbiel-pk/</link>
		<comments>http://www.straightstocks.com/stock-watch/bullish-technical-breakout-alerts-nasdaqncoc-otcbiel-pk/#comments</comments>
		<pubDate>Tue, 10 Nov 2009 03:44:13 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=788</guid>
		<description><![CDATA[Miv Investments Inc. has initiated an independent bullish technical trading alert for 11/10/09 on National Coal Corp. (NASDAQ:NCOC) and BioElectronics Corp. (OTC:BIEL.PK). BioElectronics Corp. gained tremendous buying pressure leading into market close, and National Coal Corp. saw its shares rise 7.62% within after hours trading on high volume.


About National Coal Corp.
National Coal Corp. is engaged [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/bullish-technical-breakout-alerts-nasdaqncoc-otcbiel-pk/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
		<item>
		<title>Burning the Calories with CardioCor (PINK:CDOI.PK)</title>
		<link>http://www.straightstocks.com/stock-watch/burning-the-calories-with-cardiocor-pinkcdoi-pk/</link>
		<comments>http://www.straightstocks.com/stock-watch/burning-the-calories-with-cardiocor-pinkcdoi-pk/#comments</comments>
		<pubDate>Wed, 04 Nov 2009 12:46:53 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=777</guid>
		<description><![CDATA[CARDIO INFRARED TECHNOLOGIES INC.

(Public, PINK:CDOI.PK)

http://cardio-cor.com/

MiV Investments Inc. has initiated independent research coverage on Cardio Infrared  Techs Inc, a company that looks to profit as America#8217;s negative habbits and lifestyles begin to catch up to them. Their phase II Clinical trials are set to be completed by 4Q09, and  it couldn#8217;t come at a [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/burning-the-calories-with-cardiocor-pinkcdoi-pk/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Awaiting IND Targetting a Twenty-Eight Billion Dollar Market (OTC:ACTC.OB)</title>
		<link>http://www.straightstocks.com/stock-watch/awaiting-ind-targetting-a-twenty-eight-billion-dollar-market-otcactc-ob/</link>
		<comments>http://www.straightstocks.com/stock-watch/awaiting-ind-targetting-a-twenty-eight-billion-dollar-market-otcactc-ob/#comments</comments>
		<pubDate>Mon, 02 Nov 2009 13:15:48 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=768</guid>
		<description><![CDATA[Advanced Cell Technology, Inc.
(Public, OTC:ACTC.OB)
MiV Investments Inc. has initiated independent research coverage on Advanced Cell Technology Inc. (OTC:ACTC.OB), which is anticipating  a filing of an investigational new drug (IND) application which takes on a 28B Age-related macular degeneration (AMD)  market, with over 30 million people affected by the disease. The company expects to [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/awaiting-ind-targetting-a-twenty-eight-billion-dollar-market-otcactc-ob/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Empowering Alternative Renewable Energy from Disposable Waste (PINK:WTWO.PK)</title>
		<link>http://www.straightstocks.com/stock-watch/empowering-alternative-renewable-energy-from-disposable-waste-pinkwtwo-pk/</link>
		<comments>http://www.straightstocks.com/stock-watch/empowering-alternative-renewable-energy-from-disposable-waste-pinkwtwo-pk/#comments</comments>
		<pubDate>Tue, 27 Oct 2009 12:04:31 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=756</guid>
		<description><![CDATA[W2 ENERGY, Inc.

(PINK:WTWO.PK)
MiV Investments initiates an independent company profile on W2 Energy, Inc. (PINK:WTWO.PK), which looks to breakthrough within a $23B bio-fuel industry, as a successful alternative renewable energy company amongst worldwide rising oil and energy prices. since the dawn of technological advancements, the world has relied on the burning of fossil fuels in order [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/empowering-alternative-renewable-energy-from-disposable-waste-pinkwtwo-pk/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>BioCurex Poised for Positive Future Based on Results (OTC:BOCX)</title>
		<link>http://www.straightstocks.com/stock-watch/biocurex-poised-for-positive-future-based-on-results-otcbocx/</link>
		<comments>http://www.straightstocks.com/stock-watch/biocurex-poised-for-positive-future-based-on-results-otcbocx/#comments</comments>
		<pubDate>Mon, 26 Oct 2009 14:55:22 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=742</guid>
		<description><![CDATA[BioCurex Inc
(Public, OTC:BOCX)
http://www.biocurex.com/
BioCurex, Inc. (“BioCurex” or “the Company”) is a biotechnology company developing products for cancerdiagnosis, imaging, and therapy that target a global oncology market forecast to reach over $50 billion by 2009. The Company uses a novel, patented technology based on the RECAF™ cancer marker, discovered by Dr. Ricardo Moro-Vidal, BioCurex’s chief executive officer [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/biocurex-poised-for-positive-future-based-on-results-otcbocx/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>A New Spotlight on Diverse Media Group (PINK:DVME.PK)</title>
		<link>http://www.straightstocks.com/stock-watch/a-new-spotlight-on-diverse-media-group-pinkdvme-pk/</link>
		<comments>http://www.straightstocks.com/stock-watch/a-new-spotlight-on-diverse-media-group-pinkdvme-pk/#comments</comments>
		<pubDate>Thu, 22 Oct 2009 11:16:37 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=729</guid>
		<description><![CDATA[Diverse Media Group Inc.

(Public, PINK:DVME.PK)
MiV Investments profiles Diverse Media Group (PINK:DVME.PK) which has recently made a 50% acquisition of Celebrities in Action, Inc. which has a joint venture with Stan Lee, and has agreed to sign up for the responsibilities in regards to finding high profile celebrities and athletes for their movie roles. It is [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/a-new-spotlight-on-diverse-media-group-pinkdvme-pk/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>XTend Medical Set to Redefine Cancer Detection With Nanotechnology (PINK:XMDC.PK)</title>
		<link>http://www.straightstocks.com/stock-watch/xtend-medical-set-to-redefine-cancer-detection-with-nanotechnology-pinkxmdc-pk/</link>
		<comments>http://www.straightstocks.com/stock-watch/xtend-medical-set-to-redefine-cancer-detection-with-nanotechnology-pinkxmdc-pk/#comments</comments>
		<pubDate>Tue, 20 Oct 2009 11:53:46 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=714</guid>
		<description><![CDATA[XTEND MEDICAL CORP

(Public, PINK:XMDC)

Cancer has quickly become one of the deadliest diseases, causing well over 13% of all human deaths. Cancer rates could further increase by 50% to 15 million new cases in the year 2020, according to the World Cancer Report, the most comprehensive global examination of the disease to date. Due to this [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/xtend-medical-set-to-redefine-cancer-detection-with-nanotechnology-pinkxmdc-pk/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Holiday Season May Bring Renewed Interest in BizAuctions (OTC:BZCN.PK)</title>
		<link>http://www.straightstocks.com/stock-watch/holiday-season-may-bring-renewed-interest-in-bizauctions-otcbzcn-pk/</link>
		<comments>http://www.straightstocks.com/stock-watch/holiday-season-may-bring-renewed-interest-in-bizauctions-otcbzcn-pk/#comments</comments>
		<pubDate>Fri, 16 Oct 2009 12:37:39 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=697</guid>
		<description><![CDATA[BizAuctions Inc.
(Public, OTC:BZCN.PK)
As the holiday season fast approaches during one of the most hard hit economic times in recent memory, certain discount companies look to profit and gain recognition, differentiating themselves from the pack. One of these such companies is BizAuctions Inc. (OTC:BZCN.PK), which is quickly gaining momentum in a $60B excess inventory liquidation  market. [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/holiday-season-may-bring-renewed-interest-in-bizauctions-otcbzcn-pk/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>AVAX Currently Pending Clinical Trials News for its Pipeline (OTC:AVXT.PK)</title>
		<link>http://www.straightstocks.com/stock-watch/avax-currently-pending-clinical-trials-news-for-its-pipeline-otcavxt-pk/</link>
		<comments>http://www.straightstocks.com/stock-watch/avax-currently-pending-clinical-trials-news-for-its-pipeline-otcavxt-pk/#comments</comments>
		<pubDate>Wed, 14 Oct 2009 08:25:22 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=683</guid>
		<description><![CDATA[AVAX Technologies, Inc.
(Public, OTC:AVXT.PK)
AVAX Technologies, Inc. has gone through a vast number of ups and downs throughout 2006 to 2007. At this time StocksHaven Investments profiles the company and takes look at what investors may expect within the near future. 

AVAX had a number of expectations to meet in order to sustain ongoing business operations: [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/avax-currently-pending-clinical-trials-news-for-its-pipeline-otcavxt-pk/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
		<item>
		<title>A Renewed Sense of Optimism in Paradigm Medical (OTC:PDMI.PK)</title>
		<link>http://www.straightstocks.com/stock-watch/a-renewed-sense-of-optimism-in-paradigm-medical-otcpdmi-pk/</link>
		<comments>http://www.straightstocks.com/stock-watch/a-renewed-sense-of-optimism-in-paradigm-medical-otcpdmi-pk/#comments</comments>
		<pubDate>Tue, 13 Oct 2009 08:45:17 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=677</guid>
		<description><![CDATA[Paradigm Medical Industries, Inc.
(Public, OTC:PDMI.PK)
The Medical device industry has been one of the most successful industries within 2008 and 2009, and 2010 should continue that trend. StocksHaven Investments profiles Paradigm Medical Industries, Inc., a promising company who will soon begin to introduce the first of its four new ophthalmic diagnostic devices, the Paravue, during the [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/a-renewed-sense-of-optimism-in-paradigm-medical-otcpdmi-pk/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
		<item>
		<title>FDA Medical Device: Non-Invasive Cervical Cancer Detection (OTC:GTHP)</title>
		<link>http://www.straightstocks.com/stock-watch/fda-medical-device-non-invasive-cervical-cancer-detection-otcgthp/</link>
		<comments>http://www.straightstocks.com/stock-watch/fda-medical-device-non-invasive-cervical-cancer-detection-otcgthp/#comments</comments>
		<pubDate>Thu, 08 Oct 2009 06:57:40 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=666</guid>
		<description><![CDATA[Guided Therapeutics, Inc.
(Public, OTC:GTHP)
Guided Therapeutics, Inc. (OTC:GTHP) contains perhaps one of the most promising medical devices aiming for an annual global $1 billion dollar non-invasive cervical cancer market. Now, lets take a look at how it sits alongside the likes of Nephros (OTC:NEPH) and Imaging3 (OTC:IMGG). Their device LightTouch is a powerful and innovative non-invasive [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/fda-medical-device-non-invasive-cervical-cancer-detection-otcgthp/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Why Soligenix Will be Successful (OTC:SNGX.OB)</title>
		<link>http://www.straightstocks.com/stock-watch/why-soligenix-will-be-successful-otcsngx-ob/</link>
		<comments>http://www.straightstocks.com/stock-watch/why-soligenix-will-be-successful-otcsngx-ob/#comments</comments>
		<pubDate>Wed, 07 Oct 2009 04:11:33 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=647</guid>
		<description><![CDATA[Soligenix, Inc.
(Public, OTC:SNGX)

Soligenix truly is a magnificent company, its no wonder the government also favours it so much by pouring in grants and funding. It stands tall amongst the other struggling small cap biotechs, and even after changing its company info from DORB Pharma (OTC:DORB.OB) to Soligenix (OTC:SNGX.OB), it remains ahead of the pack while [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/why-soligenix-will-be-successful-otcsngx-ob/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
<enclosure url="http://www.dorbiopharma.com/audio/rrshq15.mp3" length="20976800" type="audio/mpeg" />
		</item>
		<item>
		<title>FDA Play: Soligenix, Poised for a Stellar Comeback (OTC:SNGX.OB)</title>
		<link>http://www.straightstocks.com/stock-watch/fda-play-soligenix-poised-for-a-stellar-comeback-otcsngx-ob/</link>
		<comments>http://www.straightstocks.com/stock-watch/fda-play-soligenix-poised-for-a-stellar-comeback-otcsngx-ob/#comments</comments>
		<pubDate>Fri, 02 Oct 2009 08:23:54 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=639</guid>
		<description><![CDATA[Soligenix, Inc.
(Public, OTC:SNGX)
The past year and a half has come to be known as the rise of the small cap biotechs #8212; Anyone want to contact Steven Spielberg for a movie suggestion? Terminator: Rise of the Machines, oh please. Nothing seems to stand in the way of these once forgotten ghosts, as they are now [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/fda-play-soligenix-poised-for-a-stellar-comeback-otcsngx-ob/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Can American Scientific be the Next Big Thing? (PINK:ASFX)</title>
		<link>http://www.straightstocks.com/stock-watch/can-american-scientific-be-the-next-big-thing-pinkasfx/</link>
		<comments>http://www.straightstocks.com/stock-watch/can-american-scientific-be-the-next-big-thing-pinkasfx/#comments</comments>
		<pubDate>Fri, 02 Oct 2009 05:10:03 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=634</guid>
		<description><![CDATA[American Scientific Resources, Inc.
(Public, PINK:ASFX)
With the recent explosive gains in Spongetech Delivery Systems, investors were left endlessly searching  for that elusive replacement in their investment portfolio, which was quickly becoming nearly impossible to find #8212; then came American Scientific Resources, Inc. (PINK:ASFX). The similarities between the two couldn#8217;t be closer if we had a genie [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/can-american-scientific-be-the-next-big-thing-pinkasfx/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>An Exciting Upcoming 4Q09 for NeoPharm (OTC:NEOL)</title>
		<link>http://www.straightstocks.com/stock-watch/an-exciting-upcoming-4q09-for-neopharm-otcneol/</link>
		<comments>http://www.straightstocks.com/stock-watch/an-exciting-upcoming-4q09-for-neopharm-otcneol/#comments</comments>
		<pubDate>Wed, 30 Sep 2009 06:55:07 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=630</guid>
		<description><![CDATA[NeoPharm, Inc.
(Public, OTC:NEOL)
At first glance, NeoPharm Inc. (OTC:NEOL) seems like just another regular cancer FDA play, however upon closer inspection there are numerous key facts that set it apart, making it a valuable investment option for biotech enthusiasts. Here at StocksHaven Investments, we don#8217;t just like this company #8212; we like it a lot! Firstly, [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/an-exciting-upcoming-4q09-for-neopharm-otcneol/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Conference Call – avVaa World Health Care Products Inc.</title>
		<link>http://www.straightstocks.com/stock-watch/conference-call-%e2%80%93-avvaa-world-health-care-products-inc/</link>
		<comments>http://www.straightstocks.com/stock-watch/conference-call-%e2%80%93-avvaa-world-health-care-products-inc/#comments</comments>
		<pubDate>Tue, 29 Sep 2009 21:07:23 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=621</guid>
		<description><![CDATA[avVaa World Health Care Products Inc.

(OTC:AVVH)
At approximately 3:00pm EST, 9/29/09, StocksHaven Investments began the call conference scheduled with Founder, Chairman, and CEO of avVaa World Health Care Products Inc., Mr. Jack Farley, whom was also joined by President and COO, Ms. Lorie Campbell-Farley. The basis of the interview was to provide an executive summary, along [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/conference-call-%e2%80%93-avvaa-world-health-care-products-inc/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>An Opportunity Amongst Uncertainty (OTC:MCUJ)</title>
		<link>http://www.straightstocks.com/stock-watch/an-opportunity-amongst-uncertainty-otcmcuj/</link>
		<comments>http://www.straightstocks.com/stock-watch/an-opportunity-amongst-uncertainty-otcmcuj/#comments</comments>
		<pubDate>Fri, 25 Sep 2009 02:02:21 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=610</guid>
		<description><![CDATA[Medicure Inc.
(Public, OTC:MCUJ)
We all love that feel good story of a company riddled with uncertainty and financial distress, which bounces back and maximizes its opportunity. Medicure Inc. (OTC:MCUJ) offers just that, and more. A company whose entity and nature had long been forgotten, barely clinging on low volume, yet glistening with potential. A true diamond [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/an-opportunity-amongst-uncertainty-otcmcuj/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>avVaa Conference Call Postponed to 9/29/09 (OTC:AVVH)</title>
		<link>http://www.straightstocks.com/stock-watch/avvaa-conference-call-postponed-to-92909-otcavvh/</link>
		<comments>http://www.straightstocks.com/stock-watch/avvaa-conference-call-postponed-to-92909-otcavvh/#comments</comments>
		<pubDate>Wed, 23 Sep 2009 06:00:57 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=605</guid>
		<description><![CDATA[avVaa World Health Care Products Inc.
(Public, OTC:AVVH)
At this time, StocksHaven Investments would like to announce that the expected 9/23/09 conference call with avVaa Chairman and CEO, Jack Farley has been pushed back to 9/29/09 due to undisclosed personal reasons by Mr. Farley. However, investors have more reason to be excited over waiting the additional six [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/avvaa-conference-call-postponed-to-92909-otcavvh/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Update: Biovest Aims for BLA, not NDA (OTC:BVTI)</title>
		<link>http://www.straightstocks.com/stock-watch/update-biovest-aims-for-bla-not-nda-otcbvti/</link>
		<comments>http://www.straightstocks.com/stock-watch/update-biovest-aims-for-bla-not-nda-otcbvti/#comments</comments>
		<pubDate>Wed, 23 Sep 2009 03:39:51 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=587</guid>
		<description><![CDATA[Biovest International, Inc.
(Public, OTC:BVTI)
Today, on 9/22/09, StocksHaven Investments had the opportunity of speaking to the Investor Relations representative at Biovest International Inc., Douglas W. Calder regarding the recent profile we conducted. A few minor erroneous details were present, and thus we are issuing a company verified update to clarify these issues.
The first problem at hand [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/update-biovest-aims-for-bla-not-nda-otcbvti/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Biovest Inches Closer to Cancer Vaccine BLA Filing (OTC:BVTI)</title>
		<link>http://www.straightstocks.com/stock-watch/biovest-inches-closer-to-cancer-vaccine-bla-filing-otcbvti/</link>
		<comments>http://www.straightstocks.com/stock-watch/biovest-inches-closer-to-cancer-vaccine-bla-filing-otcbvti/#comments</comments>
		<pubDate>Tue, 22 Sep 2009 03:50:41 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=567</guid>
		<description><![CDATA[Biovest International, Inc.
(Public, OTC:BVTI)
As individuals in our respective societies, we all abide by a certain  moral standing. However, regardless of your lifestyle, you will adhere to the notion that there is no greater feeling in the world than knowing you are helping fund a company which could potentially save millions of lives, while at [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/biovest-inches-closer-to-cancer-vaccine-bla-filing-otcbvti/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Conference Call with avVaa CEO, Jack Farley (OTC:AVVH)</title>
		<link>http://www.straightstocks.com/stock-watch/conference-call-with-avvaa-ceo-jack-farley-otcavvh/</link>
		<comments>http://www.straightstocks.com/stock-watch/conference-call-with-avvaa-ceo-jack-farley-otcavvh/#comments</comments>
		<pubDate>Mon, 21 Sep 2009 05:43:29 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[avVaa World Health Care Products Inc.]]></category>
		<category><![CDATA[ceo]]></category>
		<category><![CDATA[Founder and Lead Investment Analyst]]></category>
		<category><![CDATA[Jack Farley]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[newsletter distribution services]]></category>
		<category><![CDATA[online credit card payment problems]]></category>
		<category><![CDATA[president and director]]></category>
		<category><![CDATA[StocksHaven Investments company]]></category>
		<category><![CDATA[StocksHaven Investments;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=557</guid>
		<description><![CDATA[avVaa World Health Care Products Inc.
(Public, OTC:AVVH)
At this time we would like to announce that StocksHaven Investments and avVaa World Health Care Products Inc. have reached an agreement with regards to a six month investor relations contract. This contract includes three articles, two conference calls and ongoing company updates through our newsletter distribution services. Furthermore, [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/conference-call-with-avvaa-ceo-jack-farley-otcavvh/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA Play: Redefining Breast Cancer Detection (OTC:LLBO)</title>
		<link>http://www.straightstocks.com/stock-watch/fda-play-redefining-breast-cancer-detection-otcllbo/</link>
		<comments>http://www.straightstocks.com/stock-watch/fda-play-redefining-breast-cancer-detection-otcllbo/#comments</comments>
		<pubDate>Fri, 18 Sep 2009 04:54:46 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[achieved technology levels]]></category>
		<category><![CDATA[BioElectronics Corp.]]></category>
		<category><![CDATA[Blue channel]]></category>
		<category><![CDATA[breast biopsy products]]></category>
		<category><![CDATA[Breast Cancer]]></category>
		<category><![CDATA[breast cancer detection products]]></category>
		<category><![CDATA[breast cancers]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[cancer detection system]]></category>
		<category><![CDATA[cancer detection;]]></category>
		<category><![CDATA[Cancers]]></category>
		<category><![CDATA[care physician]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[ceo]]></category>
		<category><![CDATA[computer software]]></category>
		<category><![CDATA[conventional and digital mammography systems]]></category>
		<category><![CDATA[detection systems]]></category>
		<category><![CDATA[Diagnostic Products]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[health care systems;]]></category>
		<category><![CDATA[Jim Holmes]]></category>
		<category><![CDATA[Lifeline Biotechnologies Inc.]]></category>
		<category><![CDATA[magnetic resonance imaging]]></category>
		<category><![CDATA[magnetic resonance imaging products]]></category>
		<category><![CDATA[medical technology]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Nevada]]></category>
		<category><![CDATA[non-breast-specific diagnostic technologies]]></category>
		<category><![CDATA[non-imaging]]></category>
		<category><![CDATA[non-imaging technology]]></category>
		<category><![CDATA[nuclear imaging products]]></category>
		<category><![CDATA[ovarian cancer]]></category>
		<category><![CDATA[Peaceful Trading - Vlad Moraru]]></category>
		<category><![CDATA[pharmacogenetic and prognostic testing products]]></category>
		<category><![CDATA[physician]]></category>
		<category><![CDATA[Reno]]></category>
		<category><![CDATA[stage disease]]></category>
		<category><![CDATA[susceptibility testing products]]></category>
		<category><![CDATA[technology advances;]]></category>
		<category><![CDATA[Treat Diseases Inc.]]></category>
		<category><![CDATA[treatment of breast cancer]]></category>
		<category><![CDATA[tumor]]></category>
		<category><![CDATA[tumors]]></category>
		<category><![CDATA[ultrasound]]></category>
		<category><![CDATA[ultrasound products]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[various disease]]></category>
		<category><![CDATA[What am;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=550</guid>
		<description><![CDATA[Lifeline Biotechnologies Inc.
(Public, PINK:LLBO)
With the recent gains in Hard to Treat Diseases Inc. (PINK:HTDS) and BioElectronics Corp. (OTC:BIEL), investors were left hungry for more undervalued, high potential biotech companies #8212; Then came LifeLine Biotechnologies Inc (OTC:LLBO). As technology continues to redefine the modern era of medical advancements, certain companies will stand apart from the rest, [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/fda-play-redefining-breast-cancer-detection-otcllbo/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Taking Cancer Treatment to a New Level (OTC:PVCT)</title>
		<link>http://www.straightstocks.com/stock-watch/taking-cancer-treatment-to-a-new-level-otcpvct/</link>
		<comments>http://www.straightstocks.com/stock-watch/taking-cancer-treatment-to-a-new-level-otcpvct/#comments</comments>
		<pubDate>Wed, 16 Sep 2009 04:11:03 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[actress]]></category>
		<category><![CDATA[American Society of Clinical Oncology;]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[and plans to sell]]></category>
		<category><![CDATA[and plans to sell products]]></category>
		<category><![CDATA[Atopic Dermatitis]]></category>
		<category><![CDATA[Australia]]></category>
		<category><![CDATA[Biopharmaceutical]]></category>
		<category><![CDATA[Blue channel]]></category>
		<category><![CDATA[Bob Marley;]]></category>
		<category><![CDATA[Breast Cancer]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Cancer of the skin]]></category>
		<category><![CDATA[Cancers]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[Cybill Shepherd]]></category>
		<category><![CDATA[device systems]]></category>
		<category><![CDATA[Elizabeth Taylor]]></category>
		<category><![CDATA[Eva Cassidy]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[FDA protocol]]></category>
		<category><![CDATA[Florida]]></category>
		<category><![CDATA[Healthcare Industry]]></category>
		<category><![CDATA[invasive products]]></category>
		<category><![CDATA[John F. Thompson]]></category>
		<category><![CDATA[john mccain]]></category>
		<category><![CDATA[lead investigator]]></category>
		<category><![CDATA[Liver Cancer]]></category>
		<category><![CDATA[malignant melanomas]]></category>
		<category><![CDATA[Melanoma]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[New York City]]></category>
		<category><![CDATA[Orlando]]></category>
		<category><![CDATA[owned subsidiaries]]></category>
		<category><![CDATA[prescription drug products]]></category>
		<category><![CDATA[Professor]]></category>
		<category><![CDATA[Provectus Biotech Inc.]]></category>
		<category><![CDATA[Provectus Devicetech Inc.]]></category>
		<category><![CDATA[Provectus Imaging Inc. IP]]></category>
		<category><![CDATA[Provectus Pharmaceuticals Inc.]]></category>
		<category><![CDATA[Provectus Pharmatech Inc.]]></category>
		<category><![CDATA[psoriasis]]></category>
		<category><![CDATA[PURE;]]></category>
		<category><![CDATA[PV-10]]></category>
		<category><![CDATA[Ronald Reagan]]></category>
		<category><![CDATA[Sam Donaldson]]></category>
		<category><![CDATA[skin cancer]]></category>
		<category><![CDATA[skin cancers]]></category>
		<category><![CDATA[surgery]]></category>
		<category><![CDATA[thin tumours]]></category>
		<category><![CDATA[treatment for melanoma]]></category>
		<category><![CDATA[treatment of psoriasis]]></category>
		<category><![CDATA[tumor]]></category>
		<category><![CDATA[tumors]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[World Health Organization]]></category>
		<category><![CDATA[Xantech Pharmaceuticals Inc.]]></category>
		<category><![CDATA[Yahoo]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=542</guid>
		<description><![CDATA[Provectus Pharmaceuticals, Inc.
(Public, OTC:PVCT)
StocksHaven Investments profiles one of the most exciting up-and-coming anti-cancer companies in the industry, Provectus Pharmaceuticals (OTC:PVCT). They have one of the deepest pipelines of any small cap biotech, focusing on treatments for: Melanoma, Psoriasis, Atopic Dermatitis, Breast Cancer, and Liver Metastasis. With three drugs nearly ready to enter Phase III, including [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/taking-cancer-treatment-to-a-new-level-otcpvct/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA Play: Revolutionary Medical Device (OTC:IMGG)</title>
		<link>http://www.straightstocks.com/stock-watch/fda-play-revolutionary-medical-device-otcimgg/</link>
		<comments>http://www.straightstocks.com/stock-watch/fda-play-revolutionary-medical-device-otcimgg/#comments</comments>
		<pubDate>Sun, 13 Sep 2009 23:31:11 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[3D medical imaging]]></category>
		<category><![CDATA[3D real time images]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[at X]]></category>
		<category><![CDATA[Behavioral]]></category>
		<category><![CDATA[Behavioral Analyst]]></category>
		<category><![CDATA[biomedical engineer]]></category>
		<category><![CDATA[bright CEO]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[cardiologist]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[ceo]]></category>
		<category><![CDATA[Dean Janes;]]></category>
		<category><![CDATA[diagnostic imaging]]></category>
		<category><![CDATA[diagnostic imaging  department]]></category>
		<category><![CDATA[Diagnostic Imaging Systems]]></category>
		<category><![CDATA[diagnostic medical imaging device]]></category>
		<category><![CDATA[digital imaging]]></category>
		<category><![CDATA[disruptive technology]]></category>
		<category><![CDATA[DViS]]></category>
		<category><![CDATA[DViS (Dominion Volumetric Imaging Scanner)]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Freedonia Group]]></category>
		<category><![CDATA[General Electric]]></category>
		<category><![CDATA[healthcare centers]]></category>
		<category><![CDATA[heart attacks;]]></category>
		<category><![CDATA[high-resolution imaging modality]]></category>
		<category><![CDATA[imaging]]></category>
		<category><![CDATA[Imaging3 Inc.]]></category>
		<category><![CDATA[internal injuries]]></category>
		<category><![CDATA[less expensive tools]]></category>
		<category><![CDATA[low-resolution imaging modality]]></category>
		<category><![CDATA[magnetic resonance imaging]]></category>
		<category><![CDATA[Major]]></category>
		<category><![CDATA[medical device manufacturer]]></category>
		<category><![CDATA[medical diagnostic]]></category>
		<category><![CDATA[medical diagnostic imaging market]]></category>
		<category><![CDATA[medical imaging]]></category>
		<category><![CDATA[medical imaging device]]></category>
		<category><![CDATA[medical imaging devices]]></category>
		<category><![CDATA[medical imaging equipment market]]></category>
		<category><![CDATA[medical imaging landscape]]></category>
		<category><![CDATA[medical technology]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Mri]]></category>
		<category><![CDATA[noninvasive imaging technology]]></category>
		<category><![CDATA[Patient Anatomy Identification & Location Software]]></category>
		<category><![CDATA[Philip Runfeldt]]></category>
		<category><![CDATA[Philips]]></category>
		<category><![CDATA[physician]]></category>
		<category><![CDATA[Professor]]></category>
		<category><![CDATA[Professor Runfeldt]]></category>
		<category><![CDATA[radical medical device]]></category>
		<category><![CDATA[Real Time]]></category>
		<category><![CDATA[real time 3D]]></category>
		<category><![CDATA[real time 3D image]]></category>
		<category><![CDATA[real time 3D imaging]]></category>
		<category><![CDATA[real time references]]></category>
		<category><![CDATA[real-time  tomographic imaging modality]]></category>
		<category><![CDATA[real-time diagnostic medical imaging]]></category>
		<category><![CDATA[Recommendation]]></category>
		<category><![CDATA[Reuters]]></category>
		<category><![CDATA[robotic surgery]]></category>
		<category><![CDATA[Siemens]]></category>
		<category><![CDATA[sports medicine]]></category>
		<category><![CDATA[StocksHaven Investments;]]></category>
		<category><![CDATA[strokes]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[the Dominion]]></category>
		<category><![CDATA[tomography]]></category>
		<category><![CDATA[top Analyst]]></category>
		<category><![CDATA[ultrasound]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[X Ray]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=527</guid>
		<description><![CDATA[Imaging3, Inc.
(Public, OTC:IMGG)
A new and radical medical device from Imaging3 Inc. (OTC:IMGG) is ready to set the standard, and revolutionize the way we look at X-ray, MRI and CT scans. Imaging 3 is currently awaiting FDA approval on their DViS (Dominion Volumetric Imaging Scanner).  Currently, medical imaging is met with challenges of long waits, [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/fda-play-revolutionary-medical-device-otcimgg/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
<enclosure url="http://www.imaging3.com/State_of_Company8-19-09.mp3" length="7203862" type="audio/mpeg" />
		</item>
		<item>
		<title>New Pain Treatment Triumphs Morphine (OTC:NPHC)</title>
		<link>http://www.straightstocks.com/stock-watch/new-pain-treatment-triumphs-morphine-otcnphc/</link>
		<comments>http://www.straightstocks.com/stock-watch/new-pain-treatment-triumphs-morphine-otcnphc/#comments</comments>
		<pubDate>Fri, 11 Sep 2009 05:52:41 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Adrenoleukodystrophy]]></category>
		<category><![CDATA[Adrenomyeloneuropathy;]]></category>
		<category><![CDATA[AMN]]></category>
		<category><![CDATA[amyotrophic lateral sclerosis]]></category>
		<category><![CDATA[anticholinergic therapeutic protein products]]></category>
		<category><![CDATA[Arthritis]]></category>
		<category><![CDATA[autoimmune disorders]]></category>
		<category><![CDATA[biologic product]]></category>
		<category><![CDATA[Biopharmaceutical]]></category>
		<category><![CDATA[Biopharmaceuticals]]></category>
		<category><![CDATA[Biotech Company]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Blue channel]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[ceo]]></category>
		<category><![CDATA[covering]]></category>
		<category><![CDATA[covering technologies]]></category>
		<category><![CDATA[cramps]]></category>
		<category><![CDATA[Decision Resources Inc.]]></category>
		<category><![CDATA[designer]]></category>
		<category><![CDATA[Designer Diagnostics Inc.]]></category>
		<category><![CDATA[drug addiction;]]></category>
		<category><![CDATA[drug delivery]]></category>
		<category><![CDATA[drug development]]></category>
		<category><![CDATA[Drug Discovery]]></category>
		<category><![CDATA[drug discovery subsidiary;]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Florida]]></category>
		<category><![CDATA[hepatitis]]></category>
		<category><![CDATA[HIV]]></category>
		<category><![CDATA[HIV technologies]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[joint pain]]></category>
		<category><![CDATA[lower back pain]]></category>
		<category><![CDATA[Miami]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[migraines;]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[Multiple Sclerosis]]></category>
		<category><![CDATA[Myasthenia gravis]]></category>
		<category><![CDATA[Nanologix Inc.]]></category>
		<category><![CDATA[neck aches]]></category>
		<category><![CDATA[neuralgia]]></category>
		<category><![CDATA[neurological disorder]]></category>
		<category><![CDATA[neurological disorders]]></category>
		<category><![CDATA[Nutra Pharma Corp.;]]></category>
		<category><![CDATA[Nutra Pharma Inc.]]></category>
		<category><![CDATA[Orange channel]]></category>
		<category><![CDATA[pain]]></category>
		<category><![CDATA[Pharmaceutical]]></category>
		<category><![CDATA[Pharmaceutical Products]]></category>
		<category><![CDATA[prized product]]></category>
		<category><![CDATA[ReceptoPharm Inc.]]></category>
		<category><![CDATA[Rheumatoid Arthritis]]></category>
		<category><![CDATA[Rik J Deitsch;]]></category>
		<category><![CDATA[RPI-MN]]></category>
		<category><![CDATA[severe chronic]]></category>
		<category><![CDATA[shared aerosol delivery technology]]></category>
		<category><![CDATA[Should Nutra Pharma Corp.]]></category>
		<category><![CDATA[shoulder pain]]></category>
		<category><![CDATA[stage biopharmaceutical;]]></category>
		<category><![CDATA[suggested retail price]]></category>
		<category><![CDATA[TB]]></category>
		<category><![CDATA[tuberculosis;]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[viral diseases;]]></category>
		<category><![CDATA[Webinar]]></category>
		<category><![CDATA[World Health Organization]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=489</guid>
		<description><![CDATA[Nutra Pharma Corp.
(Public, OTC:NPHC)
Step aside Morphine, the new king of chronic pain treatment has entered the building. With Nutra Pharma#8217;s stock rising nearly 2300% year-to-date, its time we see what all the commotion is about. StocksHaven Investments takes a closer look at Nutra Pharma Corp., which believes will begin generating significant revenues within the next [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/new-pain-treatment-triumphs-morphine-otcnphc/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Muscle Flex Inc: A Rare Investment Opportunity (OTC:MFLI)</title>
		<link>http://www.straightstocks.com/stock-watch/muscle-flex-inc-a-rare-investment-opportunity-otcmfli/</link>
		<comments>http://www.straightstocks.com/stock-watch/muscle-flex-inc-a-rare-investment-opportunity-otcmfli/#comments</comments>
		<pubDate>Thu, 10 Sep 2009 02:05:59 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[active sports]]></category>
		<category><![CDATA[aerobic devices]]></category>
		<category><![CDATA[American Express]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Arthur Levitt;]]></category>
		<category><![CDATA[Bear Stearns Western Regional Offices]]></category>
		<category><![CDATA[BUDDY Tablet Caddy]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[Canadian Intellectual Property Office;]]></category>
		<category><![CDATA[Cannes;]]></category>
		<category><![CDATA[CBWL]]></category>
		<category><![CDATA[ceo]]></category>
		<category><![CDATA[Chairman]]></category>
		<category><![CDATA[chairman and CEO]]></category>
		<category><![CDATA[Citigroup]]></category>
		<category><![CDATA[Cloris Leachman]]></category>
		<category><![CDATA[Cnbc]]></category>
		<category><![CDATA[Cohen Independent Research Group;]]></category>
		<category><![CDATA[Companies Board of Directors]]></category>
		<category><![CDATA[Company Founder]]></category>
		<category><![CDATA[Current Market Capital]]></category>
		<category><![CDATA[Danny Alex]]></category>
		<category><![CDATA[direct advertising]]></category>
		<category><![CDATA[direct advertising marketing channel]]></category>
		<category><![CDATA[Emmy Awards]]></category>
		<category><![CDATA[extreme sports]]></category>
		<category><![CDATA[fitness equipment;]]></category>
		<category><![CDATA[Flex]]></category>
		<category><![CDATA[founder]]></category>
		<category><![CDATA[Founder and CEO]]></category>
		<category><![CDATA[Gavin Keilly]]></category>
		<category><![CDATA[GBK Productions]]></category>
		<category><![CDATA[Grass Roots Research and Distribution Inc]]></category>
		<category><![CDATA[hair removal]]></category>
		<category><![CDATA[home fitness equipment]]></category>
		<category><![CDATA[home fitness product]]></category>
		<category><![CDATA[in-home fitness products]]></category>
		<category><![CDATA[intensified media exposure]]></category>
		<category><![CDATA[International Federation of Body Builders]]></category>
		<category><![CDATA[Joe Fatone]]></category>
		<category><![CDATA[Kevin Sorbo]]></category>
		<category><![CDATA[Las Vegas]]></category>
		<category><![CDATA[lower priced products]]></category>
		<category><![CDATA[media exposure]]></category>
		<category><![CDATA[Mercanti Group]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Monica Brant]]></category>
		<category><![CDATA[MTV]]></category>
		<category><![CDATA[Muscle Flex Inc.]]></category>
		<category><![CDATA[Muscle Flex™ Home Fitness Unit]]></category>
		<category><![CDATA[natural hair removal products]]></category>
		<category><![CDATA[Nukala]]></category>
		<category><![CDATA[Otc Bulletin Board]]></category>
		<category><![CDATA[Paul Cohen]]></category>
		<category><![CDATA[personal fitness product]]></category>
		<category><![CDATA[potential new products]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[Randy Jackson]]></category>
		<category><![CDATA[real life practical solutions]]></category>
		<category><![CDATA[research analyst]]></category>
		<category><![CDATA[safety products]]></category>
		<category><![CDATA[Sanford I. Weill]]></category>
		<category><![CDATA[Securities And Exchange Commission]]></category>
		<category><![CDATA[Solomon Smith Barney]]></category>
		<category><![CDATA[Sponge Tech Delivery Systems]]></category>
		<category><![CDATA[Sporting Goods Manufacturers Association]]></category>
		<category><![CDATA[sports equipment]]></category>
		<category><![CDATA[sports industry]]></category>
		<category><![CDATA[The American Music Awards]]></category>
		<category><![CDATA[the Emmy Awards]]></category>
		<category><![CDATA[The Golden Globes]]></category>
		<category><![CDATA[The MTV Music Awards]]></category>
		<category><![CDATA[The Oscars]]></category>
		<category><![CDATA[the Sundance Film Festival]]></category>
		<category><![CDATA[Top Research Analyst]]></category>
		<category><![CDATA[Total Gym]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Vice President]]></category>
		<category><![CDATA[www.cohenresearch.com]]></category>
		<category><![CDATA[www.GBKProductions.com]]></category>
		<category><![CDATA[www.grassrootsrd.com]]></category>
		<category><![CDATA[www.HoustonProjects.com]]></category>
		<category><![CDATA[www.MagicOnline.com]]></category>
		<category><![CDATA[www.VataBrasil.com]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=476</guid>
		<description><![CDATA[Muscle Flex, Inc 
(Public, OTC:MFLI)
The following article is submitted by a well experienced private investment group(Farseers) members Mr. Nukala and Mr. Sekona closely working with Stockshaven Investments, which conducted a recent conference call with Danny Alex the CEO of Muscle Flex Inc. Mr. Nukala is also a member of Cohen Investment Group, http://www.cohenresearch.com with [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/muscle-flex-inc-a-rare-investment-opportunity-otcmfli/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Investing in Gold – Better than Many Kinds of Savings Accounts</title>
		<link>http://www.straightstocks.com/stock-watch/investing-in-gold-%e2%80%93-better-than-many-kinds-of-savings-accounts/</link>
		<comments>http://www.straightstocks.com/stock-watch/investing-in-gold-%e2%80%93-better-than-many-kinds-of-savings-accounts/#comments</comments>
		<pubDate>Wed, 09 Sep 2009 21:38:30 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[investment tool]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[National Payday]]></category>
		<category><![CDATA[online payday lenders]]></category>
		<category><![CDATA[with high standards in both product]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=471</guid>
		<description><![CDATA[In order to facilitate greater savings and increase financial solidity, many consumers have traditionally turned to savings accounts.  There are many different kinds of savings accounts out there that can offer benefits.  However, in the current economic situation, other options might be more appealing than placing your money within one of the [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/investing-in-gold-%e2%80%93-better-than-many-kinds-of-savings-accounts/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>GenVec’s TNFerade Nears NDA Status (NASDAQ:GNVC)</title>
		<link>http://www.straightstocks.com/stock-watch/genvec%e2%80%99s-tnferade-nears-nda-status-nasdaqgnvc/</link>
		<comments>http://www.straightstocks.com/stock-watch/genvec%e2%80%99s-tnferade-nears-nda-status-nasdaqgnvc/#comments</comments>
		<pubDate>Wed, 09 Sep 2009 06:06:14 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[adenovector delivery]]></category>
		<category><![CDATA[adenovector delivery technology]]></category>
		<category><![CDATA[adenovector technology]]></category>
		<category><![CDATA[adenovector vaccine candidate]]></category>
		<category><![CDATA[adenovirus]]></category>
		<category><![CDATA[Agricultural Research Service]]></category>
		<category><![CDATA[Allergy]]></category>
		<category><![CDATA[America]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[and Lead Investment Analyst]]></category>
		<category><![CDATA[antibodies]]></category>
		<category><![CDATA[Antigenics Inc.]]></category>
		<category><![CDATA[Apple Inc]]></category>
		<category><![CDATA[Associate Professor]]></category>
		<category><![CDATA[balance disorders]]></category>
		<category><![CDATA[bank of america corp]]></category>
		<category><![CDATA[Barclays]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Cancer Research]]></category>
		<category><![CDATA[Cancers]]></category>
		<category><![CDATA[care for patients with balance disorders]]></category>
		<category><![CDATA[ceo]]></category>
		<category><![CDATA[Chemotherapy]]></category>
		<category><![CDATA[clinical disease]]></category>
		<category><![CDATA[Dendreon Corporation;]]></category>
		<category><![CDATA[director]]></category>
		<category><![CDATA[Douglas J. Swirsky]]></category>
		<category><![CDATA[esophageal cancer]]></category>
		<category><![CDATA[Executive Vice President]]></category>
		<category><![CDATA[Executive Vice President of Research and Development]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[fibrosis;]]></category>
		<category><![CDATA[Food Supply]]></category>
		<category><![CDATA[foot-and-mouth disease]]></category>
		<category><![CDATA[founder]]></category>
		<category><![CDATA[Gaithersburg;]]></category>
		<category><![CDATA[gene expression]]></category>
		<category><![CDATA[gene therapy]]></category>
		<category><![CDATA[GenVec Inc.]]></category>
		<category><![CDATA[Head And Neck Cancer]]></category>
		<category><![CDATA[hearing loss;]]></category>
		<category><![CDATA[HIV]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[Laszlo Zsak]]></category>
		<category><![CDATA[lead therapeutic product candidate]]></category>
		<category><![CDATA[locally advanced pancreatic cancer]]></category>
		<category><![CDATA[Major]]></category>
		<category><![CDATA[Malaria]]></category>
		<category><![CDATA[manager]]></category>
		<category><![CDATA[Marvin Grubman]]></category>
		<category><![CDATA[Maryland]]></category>
		<category><![CDATA[meat products]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[multi-purpose products]]></category>
		<category><![CDATA[National Institute of Allergy]]></category>
		<category><![CDATA[National Institute of Allergy and Infectious Diseases of the National Institutes of Health]]></category>
		<category><![CDATA[Naval Medical Research Center]]></category>
		<category><![CDATA[necrosis]]></category>
		<category><![CDATA[Oncologix Inc.]]></category>
		<category><![CDATA[Pancreatic Cancer]]></category>
		<category><![CDATA[parasitic disease]]></category>
		<category><![CDATA[Patrick Swazy]]></category>
		<category><![CDATA[Paul H. Fischer]]></category>
		<category><![CDATA[Pfizer Inc]]></category>
		<category><![CDATA[Ph.D.]]></category>
		<category><![CDATA[Pharmaceutical]]></category>
		<category><![CDATA[Plum Island Animal Disease Center]]></category>
		<category><![CDATA[president and chief executive officer]]></category>
		<category><![CDATA[Professor of Human Oncology]]></category>
		<category><![CDATA[Q1]]></category>
		<category><![CDATA[radiation]]></category>
		<category><![CDATA[rectal cancer]]></category>
		<category><![CDATA[Researchers of the Livestock Sciences]]></category>
		<category><![CDATA[Reuters]]></category>
		<category><![CDATA[Royce Micro]]></category>
		<category><![CDATA[SAIC-Frederick Inc.]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[second-generation vaccine candidate]]></category>
		<category><![CDATA[Spartan Micro]]></category>
		<category><![CDATA[stage biopharmaceutical;]]></category>
		<category><![CDATA[Steve Jobs]]></category>
		<category><![CDATA[targeted radiation therapy]]></category>
		<category><![CDATA[therapy for locally advanced pancreatic cancer]]></category>
		<category><![CDATA[TherAtoh]]></category>
		<category><![CDATA[TNFerade;]]></category>
		<category><![CDATA[TNFerade™;]]></category>
		<category><![CDATA[transcriptional start site]]></category>
		<category><![CDATA[treatment of inoperable]]></category>
		<category><![CDATA[treatment of locally advanced pancreatic cancer;]]></category>
		<category><![CDATA[treatment of pancreatic cancer]]></category>
		<category><![CDATA[treatment of various cancers;]]></category>
		<category><![CDATA[tumor]]></category>
		<category><![CDATA[tumors]]></category>
		<category><![CDATA[U.S. Department  of Agriculture]]></category>
		<category><![CDATA[U.S. Food and Drug  Administration]]></category>
		<category><![CDATA[United Kingdom]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[University of California at San Francisco]]></category>
		<category><![CDATA[University of California Irvine  Comprehensive Digestive Disease Center]]></category>
		<category><![CDATA[University of Denver]]></category>
		<category><![CDATA[University Of Wisconsin]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[USDA]]></category>
		<category><![CDATA[vaccine candidate]]></category>
		<category><![CDATA[Vaccine Research Center]]></category>
		<category><![CDATA[Vaccine Research Center/National Institute]]></category>
		<category><![CDATA[Vaccines]]></category>
		<category><![CDATA[Vice President and Chief Financial Officer]]></category>
		<category><![CDATA[Vice President of Research and Development]]></category>
		<category><![CDATA[Wisconsin]]></category>
		<category><![CDATA[Yahoo]]></category>
		<category><![CDATA[yale]]></category>
		<category><![CDATA[Yale University School of Medicine]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=465</guid>
		<description><![CDATA[GenVec, Inc.
(Public, NASDAQ:GNVC)
StocksHaven Investments profiles a clinical stage biopharmaceutical company developing gene-based therapeutic drugs and vaccines. Its lead product candidate, TNFerade biologic (TNFerade), is being developed for use in the treatment of cancer, and is currently undergoing Phase III trials which are expected to be completed by Q1 2010. In addition to its therapeutic product [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/genvec%e2%80%99s-tnferade-nears-nda-status-nasdaqgnvc/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New E-Mailing List, Free Membership</title>
		<link>http://www.straightstocks.com/stock-watch/new-e-mailing-list-free-membership/</link>
		<comments>http://www.straightstocks.com/stock-watch/new-e-mailing-list-free-membership/#comments</comments>
		<pubDate>Fri, 04 Sep 2009 19:59:12 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Founder and Lead Investment Analyst]]></category>
		<category><![CDATA[Lead Investment Analyst]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[StocksHaven Investments;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=447</guid>
		<description><![CDATA[Tired of missing out on StocksHaven Investments#8217; newest picks? Well now you don#8217;t have to worry. We have recently just put together a special distribution list, and best of all #8211; It#8217;s FREE!

Advantages: 

* Receive alerts well before articles are published #38; PR#8217;d
* Company basics #38; fundamentals will be provided
* Speak directly with Founder and [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/new-e-mailing-list-free-membership/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Three Blockbuster Drugs Seeking NDA (AMEX:AEN)</title>
		<link>http://www.straightstocks.com/stock-watch/three-blockbuster-drugs-seeking-nda-amexaen/</link>
		<comments>http://www.straightstocks.com/stock-watch/three-blockbuster-drugs-seeking-nda-amexaen/#comments</comments>
		<pubDate>Fri, 04 Sep 2009 06:15:47 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Adeona Pharmaceuticals Inc;]]></category>
		<category><![CDATA[Amgen]]></category>
		<category><![CDATA[Avonex]]></category>
		<category><![CDATA[Betaseron]]></category>
		<category><![CDATA[Betaseron®]]></category>
		<category><![CDATA[cardiovascular diseases]]></category>
		<category><![CDATA[care for MS]]></category>
		<category><![CDATA[Cha]]></category>
		<category><![CDATA[Chairman and Chief Executive Officer]]></category>
		<category><![CDATA[Chicago]]></category>
		<category><![CDATA[Chief Executive Officer]]></category>
		<category><![CDATA[Chief Executive Officer and co-founder]]></category>
		<category><![CDATA[Chief Operating Officer]]></category>
		<category><![CDATA[chronic inflammatory]]></category>
		<category><![CDATA[Co Founder]]></category>
		<category><![CDATA[cognitive impairment]]></category>
		<category><![CDATA[Colwell Clinical Laboratories]]></category>
		<category><![CDATA[Cordex Pharma Inc.]]></category>
		<category><![CDATA[CPA;]]></category>
		<category><![CDATA[Crystal Research Associates]]></category>
		<category><![CDATA[David Newsome]]></category>
		<category><![CDATA[dementia;]]></category>
		<category><![CDATA[Depression]]></category>
		<category><![CDATA[director]]></category>
		<category><![CDATA[dnaJP1]]></category>
		<category><![CDATA[drug therapy]]></category>
		<category><![CDATA[Esq   Chairman & Chief Executive Officer]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Fibromyalgia]]></category>
		<category><![CDATA[founder]]></category>
		<category><![CDATA[Hartlab LLC]]></category>
		<category><![CDATA[Immunotherapy]]></category>
		<category><![CDATA[inflammation]]></category>
		<category><![CDATA[James S. Kuo]]></category>
		<category><![CDATA[Jeffrey J. Kraws]]></category>
		<category><![CDATA[Jeffrey Wolf]]></category>
		<category><![CDATA[leading clinical scientist]]></category>
		<category><![CDATA[legal blindness]]></category>
		<category><![CDATA[M.B.A.]]></category>
		<category><![CDATA[M.S.]]></category>
		<category><![CDATA[macular degeneration]]></category>
		<category><![CDATA[Max Lyon]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Mississippi]]></category>
		<category><![CDATA[MS therapies]]></category>
		<category><![CDATA[Multiple Sclerosis]]></category>
		<category><![CDATA[National Eye Institute]]></category>
		<category><![CDATA[National MS Society]]></category>
		<category><![CDATA[National Multiple Sclerosis Society]]></category>
		<category><![CDATA[neurodegenerative diseases]]></category>
		<category><![CDATA[Nicholas Stergis]]></category>
		<category><![CDATA[oral therapies]]></category>
		<category><![CDATA[pain]]></category>
		<category><![CDATA[Pharmaceutical]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Post-partum Depression]]></category>
		<category><![CDATA[Postpartum depression]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[President and CEO]]></category>
		<category><![CDATA[progressive disease]]></category>
		<category><![CDATA[reduced vision]]></category>
		<category><![CDATA[relapsing-remitting multiple sclerosis;]]></category>
		<category><![CDATA[Rheumatoid Arthritis]]></category>
		<category><![CDATA[Steve H. Kanzer]]></category>
		<category><![CDATA[StocksHaven Investments;]]></category>
		<category><![CDATA[the American College;]]></category>
		<category><![CDATA[Treatment for Multiple Sclerosis]]></category>
		<category><![CDATA[treatment of MS]]></category>
		<category><![CDATA[treatment of unmet medical diseases]]></category>
		<category><![CDATA[Trimesta™]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Vice Chairman]]></category>
		<category><![CDATA[Vice Chairman of our board]]></category>
		<category><![CDATA[Vice Chairman of the Board]]></category>
		<category><![CDATA[vice president of business development]]></category>
		<category><![CDATA[wall street]]></category>
		<category><![CDATA[Wyeth]]></category>
		<category><![CDATA[Zinthionein]]></category>
		<category><![CDATA[ZMC]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=432</guid>
		<description><![CDATA[Adeona Pharmaceuticals, Inc. 

(Public, AMEX:AEN)

StocksHaven Investments takes a look at Adeona Pharmaceuticals, Inc. which currently has three blockbuster drugs in phase III, and are coming close to NDA status. The first being Trimesta, which tackles Multiple Sclerosis (MS) and Post-partum Depression. Secondly, Zinthionein, a product seeking treatment for Age Related Macular Degeneration (AMD). Lastly, Oral [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/three-blockbuster-drugs-seeking-nda-amexaen/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Online Presentation: Breakthrough Treatment Of Pain (OTC:NPHC)</title>
		<link>http://www.straightstocks.com/stock-watch/online-presentation-breakthrough-treatment-of-pain-otcnphc/</link>
		<comments>http://www.straightstocks.com/stock-watch/online-presentation-breakthrough-treatment-of-pain-otcnphc/#comments</comments>
		<pubDate>Wed, 02 Sep 2009 05:32:34 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[acetaminophen]]></category>
		<category><![CDATA[Adrenomyeloneuropathy;]]></category>
		<category><![CDATA[America]]></category>
		<category><![CDATA[amyotrophic lateral sclerosis]]></category>
		<category><![CDATA[Biopharmaceutical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[chairman and CEO]]></category>
		<category><![CDATA[Cobroxin]]></category>
		<category><![CDATA[designer]]></category>
		<category><![CDATA[Designer Diagnostics Inc.]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Florida]]></category>
		<category><![CDATA[hepatitis]]></category>
		<category><![CDATA[HIV]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[Join Nutra Pharma]]></category>
		<category><![CDATA[Miami]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Multiple Sclerosis]]></category>
		<category><![CDATA[Myasthenia gravis]]></category>
		<category><![CDATA[neurological disorders]]></category>
		<category><![CDATA[Nutra Pharma Corp.;]]></category>
		<category><![CDATA[ongoing chronic]]></category>
		<category><![CDATA[pain]]></category>
		<category><![CDATA[Pharmaceutical Products]]></category>
		<category><![CDATA[ReceptoPharm Inc.]]></category>
		<category><![CDATA[Rik J Deitsch;]]></category>
		<category><![CDATA[stage biopharmaceutical;]]></category>
		<category><![CDATA[StocksHaven Investments;]]></category>
		<category><![CDATA[TB]]></category>
		<category><![CDATA[tuberculosis;]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[viral diseases;]]></category>
		<category><![CDATA[way chronic]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=425</guid>
		<description><![CDATA[Nutra Pharma Corp.
(Public, OTC:NPHC)
StocksHaven Investments has confirmed they are set to profile Nutra Pharma Corp. in the coming days, and states that they have also touched base with with Investor Relations in regards to scheduling a tentative conference call with the Chairman and CEO, Rik J Deitsch. Nutra Pharma has recently made waves within the [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/online-presentation-breakthrough-treatment-of-pain-otcnphc/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Three Valuable Patents, Potential FDA Filing (OTC:PWRM)</title>
		<link>http://www.straightstocks.com/stock-watch/three-valuable-patents-potential-fda-filing-otcpwrm/</link>
		<comments>http://www.straightstocks.com/stock-watch/three-valuable-patents-potential-fda-filing-otcpwrm/#comments</comments>
		<pubDate>Tue, 01 Sep 2009 23:15:05 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[actual disease]]></category>
		<category><![CDATA[Alan B. Hollingsworth]]></category>
		<category><![CDATA[ALS]]></category>
		<category><![CDATA[Alzheimer]]></category>
		<category><![CDATA[amyotrophic lateral sclerosis]]></category>
		<category><![CDATA[antibodies]]></category>
		<category><![CDATA[Arizona]]></category>
		<category><![CDATA[author]]></category>
		<category><![CDATA[Banner Sun Health Research  Institute]]></category>
		<category><![CDATA[BC-SeraPro]]></category>
		<category><![CDATA[Breast Cancer]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Cancers]]></category>
		<category><![CDATA[ceo]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[collector]]></category>
		<category><![CDATA[diagnostic tests]]></category>
		<category><![CDATA[Director of Breast MRI]]></category>
		<category><![CDATA[ductal carcinoma in situ]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Gemologist]]></category>
		<category><![CDATA[Helen R. Park;]]></category>
		<category><![CDATA[Ira L. Goldknopf]]></category>
		<category><![CDATA[leukemia]]></category>
		<category><![CDATA[Lung Cancer]]></category>
		<category><![CDATA[Marwan Sabbagh]]></category>
		<category><![CDATA[Maryland]]></category>
		<category><![CDATA[Medical Director]]></category>
		<category><![CDATA[member]]></category>
		<category><![CDATA[Mercy Cancer]]></category>
		<category><![CDATA[Mercy Cancer Resource Center]]></category>
		<category><![CDATA[Mercy Women’s Center]]></category>
		<category><![CDATA[Michael Sklar]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Mri]]></category>
		<category><![CDATA[neurodegenerative disease;]]></category>
		<category><![CDATA[neurodegenerative diseases]]></category>
		<category><![CDATA[neurological disorders]]></category>
		<category><![CDATA[NuroPro® AD]]></category>
		<category><![CDATA[Oklahoma LLC]]></category>
		<category><![CDATA[Ph.D.]]></category>
		<category><![CDATA[pharmaceutical and diagnostic]]></category>
		<category><![CDATA[potential medical applications]]></category>
		<category><![CDATA[Power3 Medical Products Inc.;]]></category>
		<category><![CDATA[Power3;]]></category>
		<category><![CDATA[President and Chief Scientific Officer]]></category>
		<category><![CDATA[proteomics]]></category>
		<category><![CDATA[StocksHaven Investments;]]></category>
		<category><![CDATA[Sun City]]></category>
		<category><![CDATA[the Medical Director of Breast MRI]]></category>
		<category><![CDATA[treatment of breast cancer]]></category>
		<category><![CDATA[tumors]]></category>
		<category><![CDATA[U.S. Food and Drug  Administration]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=421</guid>
		<description><![CDATA[Power3 Medical Products, Inc.
(Public, OTC:PWRM)
The following company analysis has been contributed by a StocksHaven Investments affiliate and member, Michael Sklar. He has been studying the markets for several years now with a focus in undiscovered  Bio-Pharm companies.
About
Power3 Medical Products, Inc. (Power3) is primarily engaged in commercializing its intellectual properties in the area of diagnosis [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/three-valuable-patents-potential-fda-filing-otcpwrm/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Advanced Healing Now Possible (OTC:DSCI)</title>
		<link>http://www.straightstocks.com/stock-watch/advanced-healing-now-possible-otcdsci/</link>
		<comments>http://www.straightstocks.com/stock-watch/advanced-healing-now-possible-otcdsci/#comments</comments>
		<pubDate>Tue, 01 Sep 2009 06:48:43 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[amputation]]></category>
		<category><![CDATA[analog]]></category>
		<category><![CDATA[anti-microbial advanced wound care product]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Clinical Nurse Specialist]]></category>
		<category><![CDATA[Contract Manufacturing Services]]></category>
		<category><![CDATA[Derma Sciences Inc.]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[fungal infection]]></category>
		<category><![CDATA[integrated manufacturer]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[launched wound dressing product]]></category>
		<category><![CDATA[Manhasset]]></category>
		<category><![CDATA[Mary Brennan]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[New York]]></category>
		<category><![CDATA[North Shore Long Island Jewish Hospital]]></category>
		<category><![CDATA[pharmaceutical candidate]]></category>
		<category><![CDATA[private label products]]></category>
		<category><![CDATA[products]]></category>
		<category><![CDATA[Q4]]></category>
		<category><![CDATA[Quick-Med Technologies]]></category>
		<category><![CDATA[Regranex and Shire]]></category>
		<category><![CDATA[Renovo]]></category>
		<category><![CDATA[scar]]></category>
		<category><![CDATA[StocksHaven Investments;]]></category>
		<category><![CDATA[strong novel pharmaceutical candidate]]></category>
		<category><![CDATA[Systagenix]]></category>
		<category><![CDATA[Toronto]]></category>
		<category><![CDATA[United Kingdom]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[University of Southern California]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[wound-care products]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=414</guid>
		<description><![CDATA[Derma Sciences, Inc.
(Public, OTC:DSCI)
Derma Sciences is a truly unique and highly undervalued company within the micro-cap biomed space which currently targets a prescription drug market that is about 5x its present market cap. The company is developing a patented topical drug for accelerated healing and scar prevention and newly launched Advanced Wound Care products approaching [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/advanced-healing-now-possible-otcdsci/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Lung Cancer Medical Breakthrough (OTC:BMOD)</title>
		<link>http://www.straightstocks.com/stock-watch/lung-cancer-medical-breakthrough-otcbmod/</link>
		<comments>http://www.straightstocks.com/stock-watch/lung-cancer-medical-breakthrough-otcbmod/#comments</comments>
		<pubDate>Sun, 23 Aug 2009 01:58:32 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[ABC]]></category>
		<category><![CDATA[Albuquerque City Attorney’s Office]]></category>
		<category><![CDATA[America]]></category>
		<category><![CDATA[Ampex]]></category>
		<category><![CDATA[Angela Montoya]]></category>
		<category><![CDATA[automated technology]]></category>
		<category><![CDATA[Biomoda Inc.]]></category>
		<category><![CDATA[Biotechnology Associates]]></category>
		<category><![CDATA[Bladder Cancer]]></category>
		<category><![CDATA[Boston University]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[cancer detection;]]></category>
		<category><![CDATA[Cancers]]></category>
		<category><![CDATA[Cfo]]></category>
		<category><![CDATA[chair]]></category>
		<category><![CDATA[Cleveland]]></category>
		<category><![CDATA[College of Santa Fe]]></category>
		<category><![CDATA[Constance Dorian]]></category>
		<category><![CDATA[Corporate Secretary and Director]]></category>
		<category><![CDATA[Corporate Secretary and Director of Administration]]></category>
		<category><![CDATA[Director of Administration]]></category>
		<category><![CDATA[electronics]]></category>
		<category><![CDATA[electronics engineer]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[executive and entrepreneur]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[General Counsel]]></category>
		<category><![CDATA[Gordon Bennett]]></category>
		<category><![CDATA[Gustave Roussy]]></category>
		<category><![CDATA[insurance billing codes]]></category>
		<category><![CDATA[John Cousins]]></category>
		<category><![CDATA[John J. Cousins]]></category>
		<category><![CDATA[Lab Technician]]></category>
		<category><![CDATA[Los Alamos National Laboratories]]></category>
		<category><![CDATA[Lung Cancer]]></category>
		<category><![CDATA[lung cancers]]></category>
		<category><![CDATA[Medicare]]></category>
		<category><![CDATA[member]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[MIT]]></category>
		<category><![CDATA[New England Journal]]></category>
		<category><![CDATA[New Mexico]]></category>
		<category><![CDATA[New Mexico Department of Veterans Services]]></category>
		<category><![CDATA[North Carolina]]></category>
		<category><![CDATA[Ohio]]></category>
		<category><![CDATA[Optical Society of America and the New Mexico State Bar]]></category>
		<category><![CDATA[oral cancer]]></category>
		<category><![CDATA[Paris]]></category>
		<category><![CDATA[President and a Director]]></category>
		<category><![CDATA[President and CEO]]></category>
		<category><![CDATA[prevention for cancer]]></category>
		<category><![CDATA[public company CFO]]></category>
		<category><![CDATA[San Diego State University]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[Securities And Exchange Commission]]></category>
		<category><![CDATA[StocksHaven Investments;]]></category>
		<category><![CDATA[Subsequent product]]></category>
		<category><![CDATA[technology works]]></category>
		<category><![CDATA[the New England Journal of Medicine]]></category>
		<category><![CDATA[Tim Zannes]]></category>
		<category><![CDATA[Treatment Of Cancer]]></category>
		<category><![CDATA[University of California]]></category>
		<category><![CDATA[University of New Mexico]]></category>
		<category><![CDATA[University of North Carolina]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Verrity Gershin]]></category>
		<category><![CDATA[Vice President of Technical Operations]]></category>
		<category><![CDATA[Wharton School]]></category>
		<category><![CDATA[World Health Organization]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=401</guid>
		<description><![CDATA[Biomoda, Inc.
(Public, OTC:BMOD)
StocksHaven Investments profiles one of the most promising up and coming small cap biotech companies, Biomoda Inc, which has established a medical breakthrough for early lung cancer detection. It is a development-stage company. The Company is an invitro diagnostics company that develops assays, or tests, to detect cancer. These assays are performed in [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/lung-cancer-medical-breakthrough-otcbmod/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Giving Birth to a Profitable Company (OTC:IVOB)</title>
		<link>http://www.straightstocks.com/stock-watch/giving-birth-to-a-profitable-company-otcivob/</link>
		<comments>http://www.straightstocks.com/stock-watch/giving-birth-to-a-profitable-company-otcivob/#comments</comments>
		<pubDate>Sat, 22 Aug 2009 19:19:23 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[author]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[ceo]]></category>
		<category><![CDATA[Emy’s Salsa Aji Distribution Company Inc.]]></category>
		<category><![CDATA[Eric Sebastien]]></category>
		<category><![CDATA[Esposito]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[infertility]]></category>
		<category><![CDATA[INVO Bioscience Inc.;]]></category>
		<category><![CDATA[INVOcell]]></category>
		<category><![CDATA[INVOcell technology]]></category>
		<category><![CDATA[IT engineer]]></category>
		<category><![CDATA[Kathleen Karloff]]></category>
		<category><![CDATA[Latin America]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Pakistan]]></category>
		<category><![CDATA[Peru]]></category>
		<category><![CDATA[predicate device]]></category>
		<category><![CDATA[South America]]></category>
		<category><![CDATA[StocksHaven Investments;]]></category>
		<category><![CDATA[Turkey]]></category>
		<category><![CDATA[Twitter]]></category>
		<category><![CDATA[U.S. Food and Drug  Administration]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[www.klinkoo.com]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=396</guid>
		<description><![CDATA[INVO BioScience Inc
(Public, OTC:IVOB)
The following company analysis has been contributed by a StocksHaven Investments affiliate and member, Eric Sebastien. He is an entrepreneur with solid investment experience totalling fifteen years, and specializes in the small cap bio-tech field.
About
INVO BioScience Inc. (INVO Bioscience), formerly Emy’s Salsa Aji Distribution Company, Inc., is engaged in providing its INVOcell [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/giving-birth-to-a-profitable-company-otcivob/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CEO Reaffirms Positive Future Outlook (PINK:SYMW)</title>
		<link>http://www.straightstocks.com/stock-watch/ceo-reaffirms-positive-future-outlook-pinksymw/</link>
		<comments>http://www.straightstocks.com/stock-watch/ceo-reaffirms-positive-future-outlook-pinksymw/#comments</comments>
		<pubDate>Wed, 19 Aug 2009 18:21:48 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=361</guid>
		<description><![CDATA[SymPowerco Corp.
(Public, PINK:SYMW)
StocksHaven Investments Founder and Lead Investment Analyst, Mr. Michael Vlaicu and private investor, Mr. Nukka have engaged in a conversation with SymPowerco Corp CEO, Mr. John Davenport with regards to ongoing current and future business operations. Mr. Davenport shed light on the recently acquired subsidiaries Hoss Motorsports Inc., and Highline Hydrogen Hybrids Inc., [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/ceo-reaffirms-positive-future-outlook-pinksymw/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Investment Performance Update</title>
		<link>http://www.straightstocks.com/stock-watch/investment-performance-update/</link>
		<comments>http://www.straightstocks.com/stock-watch/investment-performance-update/#comments</comments>
		<pubDate>Tue, 18 Aug 2009 07:06:51 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[BioElectronics Corp.]]></category>
		<category><![CDATA[electric motor car solutions]]></category>
		<category><![CDATA[Hemispherx Biopharma Inc.;]]></category>
		<category><![CDATA[Highline Hydrogen Hybrids Systems]]></category>
		<category><![CDATA[HOSS Motor Sports]]></category>
		<category><![CDATA[Ludlow Capital Research]]></category>
		<category><![CDATA[managing partner]]></category>
		<category><![CDATA[Mesa Air Group Inc.;]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Nephros Inc.]]></category>
		<category><![CDATA[PRs]]></category>
		<category><![CDATA[retail volume]]></category>
		<category><![CDATA[Somaxon Pharmaceuticals Inc.]]></category>
		<category><![CDATA[SpongeTech Delivery Systems Inc]]></category>
		<category><![CDATA[StocksHaven Investments;]]></category>
		<category><![CDATA[SymPowerco Corp.]]></category>
		<category><![CDATA[TerreStar Corporation]]></category>
		<category><![CDATA[Tom Bustamante;]]></category>
		<category><![CDATA[Treat Diseases Inc.]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=350</guid>
		<description><![CDATA[At this time, StocksHaven Investments would like to recall and look back at the last few months of equity advice in order to showcase the proven track record. The following is a list of chosen companies which have been nothing short of stellar, giving investors much needed short term and long term gains despite the [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/investment-performance-update/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pain for Pleasure with Javelin Pharmaceuticals (AMEX:JAV)</title>
		<link>http://www.straightstocks.com/stock-watch/pain-for-pleasure-with-javelin-pharmaceuticals-amexjav/</link>
		<comments>http://www.straightstocks.com/stock-watch/pain-for-pleasure-with-javelin-pharmaceuticals-amexjav/#comments</comments>
		<pubDate>Wed, 05 Aug 2009 20:25:22 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[author]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[ceo]]></category>
		<category><![CDATA[Connecticut]]></category>
		<category><![CDATA[Dyloject]]></category>
		<category><![CDATA[Ereska]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[freelance journalist]]></category>
		<category><![CDATA[Global Industry Analysts Inc.]]></category>
		<category><![CDATA[Javelin]]></category>
		<category><![CDATA[Javelin Pharmaceutical]]></category>
		<category><![CDATA[Javelin Pharmaceuticals Inc.;]]></category>
		<category><![CDATA[Journalist]]></category>
		<category><![CDATA[large-cap pharmaceutical]]></category>
		<category><![CDATA[Martin Driscoll;]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Nicholas DeCesare]]></category>
		<category><![CDATA[pain]]></category>
		<category><![CDATA[pain management]]></category>
		<category><![CDATA[pain management products]]></category>
		<category><![CDATA[Pharmaceutical]]></category>
		<category><![CDATA[StocksHaven Investments;]]></category>
		<category><![CDATA[Therabel Pharma]]></category>
		<category><![CDATA[United Kingdom]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=346</guid>
		<description><![CDATA[Javelin Pharmaceuticals Inc.
(Public, AMEX:JAV)
The follow article has been submitted to StocksHaven Investments by Nicholas DeCesare, a highly respected investor and journalist within the biopharma realm.
Take one look at a chart of Javelin Pharmaceuticals over the past six months and you will see a stock that has doubled in price but still sits only around $2.00 [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/pain-for-pleasure-with-javelin-pharmaceuticals-amexjav/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Uncovering a Diamond in the Rough, SymPower (PINK:SYMW)</title>
		<link>http://www.straightstocks.com/stock-watch/uncovering-a-diamond-in-the-rough-sympower-pinksymw/</link>
		<comments>http://www.straightstocks.com/stock-watch/uncovering-a-diamond-in-the-rough-sympower-pinksymw/#comments</comments>
		<pubDate>Thu, 30 Jul 2009 00:32:29 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[advanced power              producer]]></category>
		<category><![CDATA[Battery Technologies]]></category>
		<category><![CDATA[Battery Technology]]></category>
		<category><![CDATA[CAD]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[Carleton University in Canada]]></category>
		<category><![CDATA[Centre of Excellence]]></category>
		<category><![CDATA[ceo]]></category>
		<category><![CDATA[Department of Mechanical and Aerospace Engineering]]></category>
		<category><![CDATA[Electricity]]></category>
		<category><![CDATA[electrochemical energy conversion              device]]></category>
		<category><![CDATA[energy              storage medium]]></category>
		<category><![CDATA[energy markets]]></category>
		<category><![CDATA[Energy Situation]]></category>
		<category><![CDATA[FE DMFC]]></category>
		<category><![CDATA[flat-plate alkaline battery technology]]></category>
		<category><![CDATA[Flowing Electrolyte Direct Methanol Fuel Cell technologies]]></category>
		<category><![CDATA[fuel cell]]></category>
		<category><![CDATA[fuel cell technologies]]></category>
		<category><![CDATA[Fuel Cells]]></category>
		<category><![CDATA[golf]]></category>
		<category><![CDATA[Hybrid Power System]]></category>
		<category><![CDATA[Hybrid Power Systems]]></category>
		<category><![CDATA[John Davenport]]></category>
		<category><![CDATA[majority-owned subsidiary;]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[oil quantities]]></category>
		<category><![CDATA[Ontario]]></category>
		<category><![CDATA[Ottawa]]></category>
		<category><![CDATA[Polygenic Power Systems Inc.]]></category>
		<category><![CDATA[power applications]]></category>
		<category><![CDATA[power producer]]></category>
		<category><![CDATA[power supply technologies]]></category>
		<category><![CDATA[Quantum]]></category>
		<category><![CDATA[Quantum Fuel Systems Technologies;]]></category>
		<category><![CDATA[rechargeable alkaline battery technology]]></category>
		<category><![CDATA[Stationary Power Supplies]]></category>
		<category><![CDATA[StocksHaven Investments;]]></category>
		<category><![CDATA[submarine systems]]></category>
		<category><![CDATA[sufficient energy]]></category>
		<category><![CDATA[SymPower]]></category>
		<category><![CDATA[SymPowerco]]></category>
		<category><![CDATA[SymPowerco CEO]]></category>
		<category><![CDATA[Toronto]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=335</guid>
		<description><![CDATA[Sympowerco Corp.
(Public, PINK:SYMW)
StocksHaven Investments analyzes one of the most undervalued alternative energy plays, which in the near future may find itself alongside the predominant players within the Fuel Cell #38; Hybrid Power Systems Research #38; Development sector.  SymPowerco is an energy technology company focused            [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/uncovering-a-diamond-in-the-rough-sympower-pinksymw/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Second Time’s a Charm for Somaxon (NASDAQ:SOMX)</title>
		<link>http://www.straightstocks.com/stock-watch/second-time%e2%80%99s-a-charm-for-somaxon-nasdaqsomx/</link>
		<comments>http://www.straightstocks.com/stock-watch/second-time%e2%80%99s-a-charm-for-somaxon-nasdaqsomx/#comments</comments>
		<pubDate>Wed, 22 Jul 2009 06:46:51 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[biomedical pharmaceutical]]></category>
		<category><![CDATA[critical initial physician]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[insomnia]]></category>
		<category><![CDATA[lead product candidate]]></category>
		<category><![CDATA[Michael Jackson]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[National Sleep Foundation]]></category>
		<category><![CDATA[nutritionist]]></category>
		<category><![CDATA[Pharmaceutical]]></category>
		<category><![CDATA[Silenor]]></category>
		<category><![CDATA[singer]]></category>
		<category><![CDATA[sleep disorders]]></category>
		<category><![CDATA[Somaxon Pharmaceuticals Inc.]]></category>
		<category><![CDATA[StocksHaven Investments;]]></category>
		<category><![CDATA[The Macro Trader]]></category>
		<category><![CDATA[treatment for insomnia]]></category>
		<category><![CDATA[treatment of insomnia]]></category>
		<category><![CDATA[United States]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=326</guid>
		<description><![CDATA[Somaxon Pharmaceuticals, Inc.
(Public, NASDAQ:SOMX)
StocksHaven Investments profiles one of the most promising biomedical pharmaceutical company involved with a PDUFA with regards to a drug which could quite possibly revolutionize the treatment for insomnia, a condition affecting over 70 million Americans. The company has been making waves the past few months as investors and institutions gain confidence [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/second-time%e2%80%99s-a-charm-for-somaxon-nasdaqsomx/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Multiple Paths for Success (PINK:HTDS)</title>
		<link>http://www.straightstocks.com/stock-watch/multiple-paths-for-success-pinkhtds/</link>
		<comments>http://www.straightstocks.com/stock-watch/multiple-paths-for-success-pinkhtds/#comments</comments>
		<pubDate>Tue, 21 Jul 2009 06:48:10 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[active pharmaceutical ingredient]]></category>
		<category><![CDATA[aforementioned technology]]></category>
		<category><![CDATA[ceo]]></category>
		<category><![CDATA[Chile]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[China Mellow Hope Inc.]]></category>
		<category><![CDATA[diphtheria]]></category>
		<category><![CDATA[Egypt]]></category>
		<category><![CDATA[escape routers]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Haemophilus]]></category>
		<category><![CDATA[hepatitis C]]></category>
		<category><![CDATA[HIV]]></category>
		<category><![CDATA[HTDS]]></category>
		<category><![CDATA[Indonesia]]></category>
		<category><![CDATA[Influenza]]></category>
		<category><![CDATA[intellectual property law]]></category>
		<category><![CDATA[medical subsidiaries]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[MS (Multiple Sclerosis)]]></category>
		<category><![CDATA[PRNewswire-FirstCall]]></category>
		<category><![CDATA[rabies]]></category>
		<category><![CDATA[ReNuYu Biochem Inc]]></category>
		<category><![CDATA[ReNuYu Biochmem PLC]]></category>
		<category><![CDATA[Russia]]></category>
		<category><![CDATA[Securities And Exchange Commission]]></category>
		<category><![CDATA[Serbia]]></category>
		<category><![CDATA[shenzhen]]></category>
		<category><![CDATA[Shenzhen Mellow Hope Pharm Industrial Co. Ltd.]]></category>
		<category><![CDATA[Slavica Bio Chem Co.]]></category>
		<category><![CDATA[StocksHaven Investments;]]></category>
		<category><![CDATA[Terry Yan]]></category>
		<category><![CDATA[tetanus]]></category>
		<category><![CDATA[The Macro Trader]]></category>
		<category><![CDATA[Treat Diseases Inc.]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Vaccines]]></category>
		<category><![CDATA[www.htdsmedical.com]]></category>
		<category><![CDATA[www.mellowhope.com]]></category>
		<category><![CDATA[www.slavicabiochem.com]]></category>
		<category><![CDATA[Yunnan Walvax Biotech Co. Ltd]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=316</guid>
		<description><![CDATA[Hard to Treat Diseases, Inc.
(Public, PINK:HTDS)
With the upcoming flu season upon us (considered between October and May with the peak of the season falling between late December and March), StocksHaven Investments highlights one of the most undervalued pink sheet penny biomedical stocks available, which not only tackles influenza treatments, but also many other harmful and [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/multiple-paths-for-success-pinkhtds/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New Credit Card Law to Take Effect in 2010 (NYSE:V) (NYSE:MA)</title>
		<link>http://www.straightstocks.com/stock-watch/new-credit-card-law-to-take-effect-in-2010-nysev-nysema/</link>
		<comments>http://www.straightstocks.com/stock-watch/new-credit-card-law-to-take-effect-in-2010-nysev-nysema/#comments</comments>
		<pubDate>Wed, 15 Jul 2009 03:41:11 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[balance transfers]]></category>
		<category><![CDATA[eliminating fixed-rate credit cards]]></category>
		<category><![CDATA[food]]></category>
		<category><![CDATA[Jeff Lawson]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[StocksHaven Investments;]]></category>
		<category><![CDATA[The Macro Trader]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=308</guid>
		<description><![CDATA[The following article was written and contributed by a highly regarded investor and member within the StocksHaven Investments community, Jeff Lawson:
With the recent passage and signing of the Credit Card Accountability, Responsibility, and Disclosure Act of 2009 (the Credit CARD Act), some changes will be coming to a credit card near you in the not-too-distant [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/new-credit-card-law-to-take-effect-in-2010-nysev-nysema/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>TerreStar-1 Nears Geostationary Orbit (NYSE:TSTR)</title>
		<link>http://www.straightstocks.com/stock-watch/terrestar-1-nears-geostationary-orbit-nysetstr/</link>
		<comments>http://www.straightstocks.com/stock-watch/terrestar-1-nears-geostationary-orbit-nysetstr/#comments</comments>
		<pubDate>Fri, 10 Jul 2009 14:53:51 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[AT&T]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[Communication Network]]></category>
		<category><![CDATA[communication satellite]]></category>
		<category><![CDATA[geostationary satellite]]></category>
		<category><![CDATA[geosynchronous network]]></category>
		<category><![CDATA[geosynchronous satellite]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Puerto Rico]]></category>
		<category><![CDATA[StocksHaven Investments;]]></category>
		<category><![CDATA[TerreStar Corporation]]></category>
		<category><![CDATA[The Macro Trader]]></category>
		<category><![CDATA[U.S. Virgin Islands]]></category>
		<category><![CDATA[United States]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=303</guid>
		<description><![CDATA[TerreStar Corporation
(Public, NASDAQ:TSTR)
TerreStar Corporation#8217;s recent launch of TerreStar-1, world#8217;s largest communication satellite is progressing nicely through the critical stages, well on its way to reaching a geostationary orbit.
TerreStar 1 will be maneuvered into a circular geostationary orbit eventually parking itself above the equator at 111 degrees West longitude to cover the United States, Canada, Puerto [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/terrestar-1-nears-geostationary-orbit-nysetstr/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Shares Seem Undervalued – Elan Corporation (NYSE:ELN)</title>
		<link>http://www.straightstocks.com/stock-watch/shares-seem-undervalued-%e2%80%93-elan-corporation-nyseeln/</link>
		<comments>http://www.straightstocks.com/stock-watch/shares-seem-undervalued-%e2%80%93-elan-corporation-nyseeln/#comments</comments>
		<pubDate>Fri, 10 Jul 2009 03:46:59 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Biogen Idec]]></category>
		<category><![CDATA[Biopharmaceuticals]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[brain infection]]></category>
		<category><![CDATA[Citigroup]]></category>
		<category><![CDATA[current CEO]]></category>
		<category><![CDATA[drug delivery]]></category>
		<category><![CDATA[Elan Corporation plc]]></category>
		<category><![CDATA[Elan Drug Technologies]]></category>
		<category><![CDATA[Elan’s blockbuster Alzheimer’s drug]]></category>
		<category><![CDATA[eln]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[huge money maker]]></category>
		<category><![CDATA[Immunotherapy]]></category>
		<category><![CDATA[Ireland]]></category>
		<category><![CDATA[Johnson]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Johnsons]]></category>
		<category><![CDATA[Kelly Martin]]></category>
		<category><![CDATA[Michael Levesque]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Moody]]></category>
		<category><![CDATA[Multiple Sclerosis]]></category>
		<category><![CDATA[neuroscience]]></category>
		<category><![CDATA[neuroscience-based biotechnology]]></category>
		<category><![CDATA[Nicholas DeCesare]]></category>
		<category><![CDATA[pain]]></category>
		<category><![CDATA[Pharmaceutical]]></category>
		<category><![CDATA[pharmaceutical giant]]></category>
		<category><![CDATA[Pharmaceutical Industry]]></category>
		<category><![CDATA[PML]]></category>
		<category><![CDATA[principal research and development]]></category>
		<category><![CDATA[progressive multifocal leukoencephalopathy]]></category>
		<category><![CDATA[severe chronic]]></category>
		<category><![CDATA[StocksHaven Investments;]]></category>
		<category><![CDATA[The Macro Trader]]></category>
		<category><![CDATA[Tysabri]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Vice President]]></category>
		<category><![CDATA[wall street]]></category>
		<category><![CDATA[Wyeth]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=293</guid>
		<description><![CDATA[Elan Corporation
(Public, NYSE:ELN)

About
Elan Corporation, plc (Elan) is a neuroscience-based biotechnology company. Its principal research and development, manufacturing and marketing facilities are located in Ireland and the United States. Elan’s operations are organized into two business units: Biopharmaceuticals and Elan Drug Technologies (EDT). Biopharmaceuticals engages in research, development and commercial activities primarily in neuroscience, autoimmune and [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/shares-seem-undervalued-%e2%80%93-elan-corporation-nyseeln/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Sky High Potential – TerreStar Corp. (NASDAQ:TSTR)</title>
		<link>http://www.straightstocks.com/stock-watch/sky-high-potential-%e2%80%93-terrestar-corp-nasdaqtstr/</link>
		<comments>http://www.straightstocks.com/stock-watch/sky-high-potential-%e2%80%93-terrestar-corp-nasdaqtstr/#comments</comments>
		<pubDate>Thu, 09 Jul 2009 16:32:04 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Arianespace]]></category>
		<category><![CDATA[AT&T]]></category>
		<category><![CDATA[broadband network]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[communications industry]]></category>
		<category><![CDATA[conventional commercial wireless devices]]></category>
		<category><![CDATA[CTO]]></category>
		<category><![CDATA[Dennis Matheson]]></category>
		<category><![CDATA[ground-based phone networks]]></category>
		<category><![CDATA[Harbinger Capital Partners Master Fd I Ltd.]]></category>
		<category><![CDATA[Harbinger Capital Partners Special Situations Fund]]></category>
		<category><![CDATA[hybrid prototype terrestrial/satellite hand]]></category>
		<category><![CDATA[integrated satellite]]></category>
		<category><![CDATA[Jeff Epstein]]></category>
		<category><![CDATA[Koss (DS-PS PSI113) Headphones]]></category>
		<category><![CDATA[land-based wireless network]]></category>
		<category><![CDATA[Launch Services]]></category>
		<category><![CDATA[leader]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[mobile broadband network services]]></category>
		<category><![CDATA[Mobile Communications]]></category>
		<category><![CDATA[mobile satellite service]]></category>
		<category><![CDATA[Mobile Satellite;]]></category>
		<category><![CDATA[Motient Corporation]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[radio systems;]]></category>
		<category><![CDATA[Reston]]></category>
		<category><![CDATA[satellite dish]]></category>
		<category><![CDATA[satellite launches]]></category>
		<category><![CDATA[similar satellite]]></category>
		<category><![CDATA[SkyTerra Communications Inc.]]></category>
		<category><![CDATA[StocksHaven Investments;]]></category>
		<category><![CDATA[TerraStar Corporation]]></category>
		<category><![CDATA[TerreStar Corporation]]></category>
		<category><![CDATA[TerreStar Global Ltd.]]></category>
		<category><![CDATA[TerreStar Networks Inc.]]></category>
		<category><![CDATA[terrestrial communications components]]></category>
		<category><![CDATA[terrestrial communications network]]></category>
		<category><![CDATA[terrestrial wireless communications network]]></category>
		<category><![CDATA[The Macro Trader]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[universal access and tailored applications]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Vanguard Group Inc;]]></category>
		<category><![CDATA[Virginia]]></category>
		<category><![CDATA[wireless communications]]></category>
		<category><![CDATA[wireless devices;]]></category>
		<category><![CDATA[www.terrestar.com]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=280</guid>
		<description><![CDATA[TerreStar Corporation
(Public, NASDAQ:TSTR)
With the recent launching of TerreStar-1, TerraStar Corporation looks to break through and become a leader in the communications industry. AT#38;T Mobility along with TerreStar Corporation will market a hybrid prototype terrestrial/satellite hand set yet this year. The technology will allow the new hand set to operate on ground-based phone networks. In dead [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/sky-high-potential-%e2%80%93-terrestar-corp-nasdaqtstr/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Playing With Fire – ARDM (OTC:ARDM)</title>
		<link>http://www.straightstocks.com/stock-watch/playing-with-fire-%e2%80%93-ardm-otcardm/</link>
		<comments>http://www.straightstocks.com/stock-watch/playing-with-fire-%e2%80%93-ardm-otcardm/#comments</comments>
		<pubDate>Wed, 08 Jul 2009 15:56:43 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[American Lung Association]]></category>
		<category><![CDATA[anthrax;]]></category>
		<category><![CDATA[Aradigm Corporation;]]></category>
		<category><![CDATA[bacterial infections]]></category>
		<category><![CDATA[bronchiectasis;]]></category>
		<category><![CDATA[CF]]></category>
		<category><![CDATA[Cipro]]></category>
		<category><![CDATA[Ciprofloxacin]]></category>
		<category><![CDATA[ciprofloxacin hydrochloride]]></category>
		<category><![CDATA[Combination Products]]></category>
		<category><![CDATA[Cystic Fibrosis]]></category>
		<category><![CDATA[Cystic Fibrosis Foundation]]></category>
		<category><![CDATA[drug delivery]]></category>
		<category><![CDATA[drug delivery technologies]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[formulation]]></category>
		<category><![CDATA[formulation technologies]]></category>
		<category><![CDATA[genetic disease]]></category>
		<category><![CDATA[Imitrex]]></category>
		<category><![CDATA[Ladenburg Thalmann]]></category>
		<category><![CDATA[lung infections]]></category>
		<category><![CDATA[marketed ciprofloxacin products]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[migraine]]></category>
		<category><![CDATA[Pharmaceutical]]></category>
		<category><![CDATA[pharmacokinetics]]></category>
		<category><![CDATA[Product Candidate]]></category>
		<category><![CDATA[pulmonary infections]]></category>
		<category><![CDATA[respiratory infections]]></category>
		<category><![CDATA[respiratory inhalation products]]></category>
		<category><![CDATA[StocksHaven Investments;]]></category>
		<category><![CDATA[sumatriptan]]></category>
		<category><![CDATA[The Macro Trader]]></category>
		<category><![CDATA[treatment for many respiratory diseases]]></category>
		<category><![CDATA[treatment of cystic fibrosis]]></category>
		<category><![CDATA[treatment of severe respiratory diseases]]></category>
		<category><![CDATA[treatment of systemic diseases]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=267</guid>
		<description><![CDATA[Aradigm Corporation
(Public, OTC:ARDM)
Aradigm is a company with a lot of potential positive long-term gains, especially with regards to its product pipeline involving the inhaled Cipro product (ILCH) for BE and CF, however the short-term play is a very different story. This company lacks visibility and the ability to fully utilize press release syndication to maximize [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/playing-with-fire-%e2%80%93-ardm-otcardm/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Why MuGard Will Be Successful</title>
		<link>http://www.straightstocks.com/stock-watch/why-mugard-will-be-successful/</link>
		<comments>http://www.straightstocks.com/stock-watch/why-mugard-will-be-successful/#comments</comments>
		<pubDate>Sat, 04 Jul 2009 23:49:35 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Access Pharmaceuticals Inc.;]]></category>
		<category><![CDATA[automatic preset media player;]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[ceo]]></category>
		<category><![CDATA[Chemotherapy]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Germany]]></category>
		<category><![CDATA[Greece]]></category>
		<category><![CDATA[Head And Neck Cancer]]></category>
		<category><![CDATA[Italy]]></category>
		<category><![CDATA[Jeff B. Davis]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Mp3]]></category>
		<category><![CDATA[mucocutaneous disorders]]></category>
		<category><![CDATA[Mucositis;]]></category>
		<category><![CDATA[oral mucositis;]]></category>
		<category><![CDATA[Radiation Therapy]]></category>
		<category><![CDATA[radiation treatment]]></category>
		<category><![CDATA[radiotherapy]]></category>
		<category><![CDATA[The Macro Trader]]></category>
		<category><![CDATA[transplantation]]></category>
		<category><![CDATA[United Kingdom]]></category>
		<category><![CDATA[United States Patent and Trademark Office;]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=258</guid>
		<description><![CDATA[Access Pharmaceuticals, Inc.
(OTC:ACCP)
Many investors have raised concerns with regards to Access Pharmaceuticals being on the OTC. Indeed more than half the time companies which are not listed on a major exchange tend to lie, cheat and do just about anything possible in order to stimulate investor demand. They will reach out to stock promoters, make [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/why-mugard-will-be-successful/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Hyperinflation Nation – The Fall of the USD</title>
		<link>http://www.straightstocks.com/stock-watch/hyperinflation-nation-%e2%80%93-the-fall-of-the-usd/</link>
		<comments>http://www.straightstocks.com/stock-watch/hyperinflation-nation-%e2%80%93-the-fall-of-the-usd/#comments</comments>
		<pubDate>Mon, 29 Jun 2009 17:13:21 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Videos]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=251</guid>
		<description><![CDATA[Random Posts

Company Watchlist #8211; April 13-17/09
BioElectronics Corp. (OTC:BIEL) #8211; A Doubled Edged Sword
Hemispherx (AMEX:HEB) Seeks Rebound: Phase 6 Flu Pandemic
NSPT is a buy]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/hyperinflation-nation-%e2%80%93-the-fall-of-the-usd/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Conference Call – Access Pharmaceuticals Inc.</title>
		<link>http://www.straightstocks.com/stock-watch/conference-call-%e2%80%93-access-pharmaceuticals-inc/</link>
		<comments>http://www.straightstocks.com/stock-watch/conference-call-%e2%80%93-access-pharmaceuticals-inc/#comments</comments>
		<pubDate>Wed, 24 Jun 2009 17:32:56 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Access Pharmaceuticals Inc.;]]></category>
		<category><![CDATA[automatic preset media player;]]></category>
		<category><![CDATA[David Luci]]></category>
		<category><![CDATA[Director & CEO]]></category>
		<category><![CDATA[Director & Consultant]]></category>
		<category><![CDATA[Jeffrey B. Davis;]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Mp3]]></category>
		<category><![CDATA[StocksHaven Investments;]]></category>
		<category><![CDATA[web browser]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=246</guid>
		<description><![CDATA[Access Pharmaceuticals Inc.
(OTC:ACCP)
At approximately 5:00pm EST, 6/23/09, StocksHaven Investments began the call conference scheduled with Director #38; CEO of Access Pharmaceuticals Inc., Mr. Jeffrey B. Davis, whom was also joined by Director #38; Consultant, Mr. David Luci. The basis of the interview was to provide an executive summary, along with their respective business strategy. Mr. [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/conference-call-%e2%80%93-access-pharmaceuticals-inc/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>BioElectronics Corp. (OTC:BIEL) – A Doubled Edged Sword</title>
		<link>http://www.straightstocks.com/stock-watch/bioelectronics-corp-otcbiel-%e2%80%93-a-doubled-edged-sword/</link>
		<comments>http://www.straightstocks.com/stock-watch/bioelectronics-corp-otcbiel-%e2%80%93-a-doubled-edged-sword/#comments</comments>
		<pubDate>Fri, 19 Jun 2009 15:09:05 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=245</guid>
		<description><![CDATA[BioElectronics Corporation
(OTC:BIEL)
BioElectronics is a company which is plagued by a poor financial balance sheet, unaudited filings and barely sustainable ongoing operations with its current expenses constantly exceeding revenues, however is it worth investing in? Here is a top-down unbiased analysis which tells all, investigating deeper into the lion#8217;s den.


About: BioElectronics Corporation (BioElectronics) designs, develops and [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/bioelectronics-corp-otcbiel-%e2%80%93-a-doubled-edged-sword/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Nephros (OTC:NEPH): Three FDA Decisions, One Company</title>
		<link>http://www.straightstocks.com/stock-watch/nephros-otcneph-three-fda-decisions-one-company/</link>
		<comments>http://www.straightstocks.com/stock-watch/nephros-otcneph-three-fda-decisions-one-company/#comments</comments>
		<pubDate>Thu, 18 Jun 2009 01:28:17 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[American Hospital Association;]]></category>
		<category><![CDATA[cholera]]></category>
		<category><![CDATA[dialysis]]></category>
		<category><![CDATA[director]]></category>
		<category><![CDATA[disease  prevention issues]]></category>
		<category><![CDATA[DSU]]></category>
		<category><![CDATA[DSU technology]]></category>
		<category><![CDATA[e-coli]]></category>
		<category><![CDATA[end stage renal disease]]></category>
		<category><![CDATA[ESRD]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[filter technologies]]></category>
		<category><![CDATA[filter technology]]></category>
		<category><![CDATA[HD190]]></category>
		<category><![CDATA[HDF]]></category>
		<category><![CDATA[hemodiafiltration]]></category>
		<category><![CDATA[hemodialysis]]></category>
		<category><![CDATA[hepatitis]]></category>
		<category><![CDATA[HIV]]></category>
		<category><![CDATA[immune systems]]></category>
		<category><![CDATA[industrial and retail  opportunities]]></category>
		<category><![CDATA[MD190]]></category>
		<category><![CDATA[Michael Sklar]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Mid-Dilution Diafiltration technology]]></category>
		<category><![CDATA[Mid-Dilution filter]]></category>
		<category><![CDATA[Mid-Dilution filter technologies]]></category>
		<category><![CDATA[Nephros Inc.]]></category>
		<category><![CDATA[Office of Naval Research]]></category>
		<category><![CDATA[Office of U.S.  Naval Research]]></category>
		<category><![CDATA[OLpur HD 190]]></category>
		<category><![CDATA[OLpur HD190]]></category>
		<category><![CDATA[OLpur MD]]></category>
		<category><![CDATA[PMA Supplement]]></category>
		<category><![CDATA[rubber gloves;]]></category>
		<category><![CDATA[similar device]]></category>
		<category><![CDATA[StocksHaven Investments;]]></category>
		<category><![CDATA[substantial infection]]></category>
		<category><![CDATA[treatment devices;]]></category>
		<category><![CDATA[U.S. Defense Department]]></category>
		<category><![CDATA[U.S. Food and Drug Administration]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[United States Marine Corps;]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Water]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=244</guid>
		<description><![CDATA[Nephros, Inc. 
(OTC: NEPH)
A reader of StocksHaven Investments by the name of Michael Sklar has contributed the following article regarding Nephros, Inc. The article outlines one of the most undervalued BioPharma companies around, at only $1.08 PPS with three pending FDA decisions. If you are an avid investor of pre-PDUFA companies, StocksHaven Investments highly suggests [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/nephros-otcneph-three-fda-decisions-one-company/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Third Time’s A Charm For Nuvo Research (TSE:NRI), (PINK:NRIFF)</title>
		<link>http://www.straightstocks.com/stock-watch/third-time%e2%80%99s-a-charm-for-nuvo-research-tsenri-pinknriff/</link>
		<comments>http://www.straightstocks.com/stock-watch/third-time%e2%80%99s-a-charm-for-nuvo-research-tsenri-pinknriff/#comments</comments>
		<pubDate>Tue, 16 Jun 2009 14:42:25 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=243</guid>
		<description><![CDATA[Nuvo Research Inc.
(TSE:NRI), (OTC:NRIFF)
Nuvo Research Inc. has been red hot this past month and is expected to continue. StocksHaven Investments has identified Nuvo Research as its top candidate for undervalued biotech pre-PDUFA. With a current PPS below $1.00 CAD, and their product Pennsaid, a new and innovative treatment for osteoarthritis having expected net sales of [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/third-time%e2%80%99s-a-charm-for-nuvo-research-tsenri-pinknriff/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Hot FDA Trade: BioDelivery Sciences International</title>
		<link>http://www.straightstocks.com/stock-watch/hot-fda-trade-biodelivery-sciences-international/</link>
		<comments>http://www.straightstocks.com/stock-watch/hot-fda-trade-biodelivery-sciences-international/#comments</comments>
		<pubDate>Sat, 13 Jun 2009 18:49:07 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[2008 Beijing Olympic Games;]]></category>
		<category><![CDATA[BEMA™ technology;]]></category>
		<category><![CDATA[BioDelivery Sciences International Inc.;]]></category>
		<category><![CDATA[Datamonitor;]]></category>
		<category><![CDATA[drug delivery technologies]]></category>
		<category><![CDATA[Drug Delivery Technology]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[European Union]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Fuels Bank;]]></category>
		<category><![CDATA[Hot FDA Trade;]]></category>
		<category><![CDATA[Meda Ab]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[ONSOLIS;]]></category>
		<category><![CDATA[owned drug delivery ;]]></category>
		<category><![CDATA[owned drug delivery technologies;]]></category>
		<category><![CDATA[pain]]></category>
		<category><![CDATA[Pharmaceutical]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[south korea]]></category>
		<category><![CDATA[StocksHaven Investments;]]></category>
		<category><![CDATA[Taiwan]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=242</guid>
		<description><![CDATA[BioDelivery Sciences International
(NASDAQ:BDSI)
Continuing with the trend of pre-FDA decision BioPharma companies, StocksHaven Investments takes a closer look at BDSI which hopes it#8217;s product Onsolis will strive past approval and make its way onto shelves world-wide.

About BDSI: BioDelivery Sciences International, Inc. is a specialty pharmaceutical company that is utilizing licensed and owned drug delivery technologies to [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/hot-fda-trade-biodelivery-sciences-international/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Hemispherx (AMEX:HEB) Seeks Rebound: Phase 6 Flu Pandemic</title>
		<link>http://www.straightstocks.com/stock-watch/hemispherx-amexheb-seeks-rebound-phase-6-flu-pandemic/</link>
		<comments>http://www.straightstocks.com/stock-watch/hemispherx-amexheb-seeks-rebound-phase-6-flu-pandemic/#comments</comments>
		<pubDate>Thu, 11 Jun 2009 17:08:53 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[acquired immunodeficiency syndrome;]]></category>
		<category><![CDATA[Aids]]></category>
		<category><![CDATA[Australia]]></category>
		<category><![CDATA[chronic fatigue syndrome;]]></category>
		<category><![CDATA[Conference Call - Hemispherx BioPharma Inc;]]></category>
		<category><![CDATA[Drug Technology;]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Hemispherx Biopharma;]]></category>
		<category><![CDATA[Hemispherx;]]></category>
		<category><![CDATA[Influenza]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[Japanese Ministry of Health;]]></category>
		<category><![CDATA[Japanese National Institute;]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[National Institutes;]]></category>
		<category><![CDATA[Pennsylvania]]></category>
		<category><![CDATA[Philadelphia]]></category>
		<category><![CDATA[StocksHaven Investments;]]></category>
		<category><![CDATA[treatment for chronic fatigue syndrome;]]></category>
		<category><![CDATA[World Health Organization]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=241</guid>
		<description><![CDATA[With the World Health Organization (WHO) officially declaring the flu a pandemic of phase 6, one company looking to make waves is Hemispherx BioPharma (AMEX:HEB).
Hemispherx has recently been in limbo awaiting FDA decision on the long-awaited treatment for Chronic Fatigue Syndrome (CFS), Ampligen.
Ampligen, also known as poly I:poly C12U, is an experimental immunomodulatory double stranded [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/hemispherx-amexheb-seeks-rebound-phase-6-flu-pandemic/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Gaining Momentum – Access Pharmaceuticals (OTC:ACCP)</title>
		<link>http://www.straightstocks.com/stock-watch/gaining-momentum-%e2%80%93-access-pharmaceuticals-otcaccp/</link>
		<comments>http://www.straightstocks.com/stock-watch/gaining-momentum-%e2%80%93-access-pharmaceuticals-otcaccp/#comments</comments>
		<pubDate>Wed, 10 Jun 2009 19:35:10 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=240</guid>
		<description><![CDATA[Access Pharmaceuticals (OTC:ACCP), a once struggling and troubled company, Access has put these issues behind them and is emerging as one of the top undervalued players in the BioPharma industry. Not only does this company have products which target a large and extensive market, but they are also implementing solid fundamentals within business management principals.

Among [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/gaining-momentum-%e2%80%93-access-pharmaceuticals-otcaccp/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Identifying Fact vs. Fiction on Hermispherx’s Ampligen</title>
		<link>http://www.straightstocks.com/stock-watch/identifying-fact-vs-fiction-on-hermispherx%e2%80%99s-ampligen/</link>
		<comments>http://www.straightstocks.com/stock-watch/identifying-fact-vs-fiction-on-hermispherx%e2%80%99s-ampligen/#comments</comments>
		<pubDate>Sun, 07 Jun 2009 17:32:12 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Call Conference - Hemispherx BioPharma Inc;]]></category>
		<category><![CDATA[Carter]]></category>
		<category><![CDATA[CDC;]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Feuerstein;]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Nick DeCesare;]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[StocksHaven Investments;]]></category>
		<category><![CDATA[technology changes;]]></category>
		<category><![CDATA[Vanderbilt University]]></category>
		<category><![CDATA[William Mitchell;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=237</guid>
		<description><![CDATA[Much to the delight of Hemispherx BioPharma individual and institutional investors, a reader and follower of StocksHaven Investments has identified several key points which have been raised recently, decyphering the fact from fiction.
The following article has been submitted by an investor named, Nick DeCesare
————-
 
After reviewing my own research, it is time to post some [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/identifying-fact-vs-fiction-on-hermispherx%e2%80%99s-ampligen/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Hemispherx Ampligen Combats H5N1</title>
		<link>http://www.straightstocks.com/stock-watch/hemispherx-ampligen-combats-h5n1/</link>
		<comments>http://www.straightstocks.com/stock-watch/hemispherx-ampligen-combats-h5n1/#comments</comments>
		<pubDate>Wed, 03 Jun 2009 22:58:06 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Avian Influenza;]]></category>
		<category><![CDATA[Cambodia]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[effector site;]]></category>
		<category><![CDATA[Facebook]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Indonesia]]></category>
		<category><![CDATA[Infectious Disease]]></category>
		<category><![CDATA[Influenza]]></category>
		<category><![CDATA[influenza in humans;]]></category>
		<category><![CDATA[Iraq]]></category>
		<category><![CDATA[Mesa Air Group;]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[StocksHaven Investments;]]></category>
		<category><![CDATA[Swine Flu;]]></category>
		<category><![CDATA[Thailand]]></category>
		<category><![CDATA[Turkey]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Vaccines]]></category>
		<category><![CDATA[Vietnam]]></category>
		<category><![CDATA[World Health Organization]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=236</guid>
		<description><![CDATA[With the majority of the focus being placed on on the current pending FDA approval regarding (AMEX:HEB) Hemispherx#8217;s Ampligen, StocksHaven Investments would like to shift the focus on the drug#8217;s ability to help treat the potential outbreak of H5N1 (Swine Flu).
Overview of H5N1
H5N1 - also called #8220;Influenza A (H5N1) virus#8221; – is an influenza  [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/hemispherx-ampligen-combats-h5n1/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Post Approval Hemispherx Ampligen PPS Evaluation</title>
		<link>http://www.straightstocks.com/stock-watch/post-approval-hemispherx-ampligen-pps-evaluation/</link>
		<comments>http://www.straightstocks.com/stock-watch/post-approval-hemispherx-ampligen-pps-evaluation/#comments</comments>
		<pubDate>Tue, 02 Jun 2009 15:54:11 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Ace Spader;]]></category>
		<category><![CDATA[Ampligen;]]></category>
		<category><![CDATA[bloomberg]]></category>
		<category><![CDATA[Chicago]]></category>
		<category><![CDATA[energy]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[finance]]></category>
		<category><![CDATA[freelance web developer;]]></category>
		<category><![CDATA[google]]></category>
		<category><![CDATA[Hemispherx Biopharma Inc.;]]></category>
		<category><![CDATA[Illinois]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Northwestern University]]></category>
		<category><![CDATA[online tools]]></category>
		<category><![CDATA[Securities And Exchange Commission]]></category>
		<category><![CDATA[StocksHaven Investments;]]></category>
		<category><![CDATA[Titan Pharmaceuticals;]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Vanda Pharmaceuticals;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=235</guid>
		<description><![CDATA[Much to the delight of Hemispherx BioPharma individual and institutional investors, a reader and follower of StocksHaven Investments has evaluated the Price Per Share potential should Ampligen see FDA approval within the coming weeks.
The following article has been submitted by an investor under the name: Ace Spader
The much anticipated FDA decision on the Hemispherx Biopharma, [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/post-approval-hemispherx-ampligen-pps-evaluation/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Consumer Confidence Index Encourages Economic Rebound, Fuels Bank Stocks C, AIG, BAC, WFC, GS, JPM</title>
		<link>http://www.straightstocks.com/stock-watch/consumer-confidence-index-encourages-economic-rebound-fuels-bank-stocks-c-aig-bac-wfc-gs-jpm/</link>
		<comments>http://www.straightstocks.com/stock-watch/consumer-confidence-index-encourages-economic-rebound-fuels-bank-stocks-c-aig-bac-wfc-gs-jpm/#comments</comments>
		<pubDate>Tue, 02 Jun 2009 03:08:50 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[2008 Beijing Olympic Games;]]></category>
		<category><![CDATA[Bank Stocks]]></category>
		<category><![CDATA[Conference Board Consumer Research Center]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Says Lynn Franco;]]></category>
		<category><![CDATA[United States]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=234</guid>
		<description><![CDATA[Confidence among U.S. consumers jumped in May by the most in six years, fueling speculation the economy will recover later this year.
The U.S. Consumer Confidence Index (CCI) is an indicator designed to measure consumer confidence, which is defined as the degree of optimism on the state of the economy that consumers are expressing through their [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/consumer-confidence-index-encourages-economic-rebound-fuels-bank-stocks-c-aig-bac-wfc-gs-jpm/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Automaker Giant Files Bankruptcy: GM</title>
		<link>http://www.straightstocks.com/stock-watch/automaker-giant-files-bankruptcy-gm/</link>
		<comments>http://www.straightstocks.com/stock-watch/automaker-giant-files-bankruptcy-gm/#comments</comments>
		<pubDate>Mon, 01 Jun 2009 16:52:46 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Videos]]></category>
		<category><![CDATA[Barack Obama]]></category>
		<category><![CDATA[Barack Obama Spoof;]]></category>
		<category><![CDATA[century-old automaker;]]></category>
		<category><![CDATA[General Motors Corp]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=233</guid>
		<description><![CDATA[(Public, NYSE:GM)
World Market News
General Motors Corp., the century-old automaker battered by the economic downturn has filed for bankruptcy. Under the plan, the government will now take 60 percent ownership in GM. (June 1)
President Barack Obama pushed General Motors Corp. into bankruptcy on Monday and said it was part of a #8220;viable achievable plan that will [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/automaker-giant-files-bankruptcy-gm/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Conference Call &#8211; Hemispherx Responds to TheStreet.com</title>
		<link>http://www.straightstocks.com/stock-watch/conference-call-hemispherx-responds-to-thestreetcom/</link>
		<comments>http://www.straightstocks.com/stock-watch/conference-call-hemispherx-responds-to-thestreetcom/#comments</comments>
		<pubDate>Fri, 29 May 2009 20:29:31 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Adam]]></category>
		<category><![CDATA[Adam Feuerstein;]]></category>
		<category><![CDATA[automatic preset media player;]]></category>
		<category><![CDATA[Carter]]></category>
		<category><![CDATA[Hemispherx Biopharma Inc.;]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Mp3]]></category>
		<category><![CDATA[StocksHaven Investments;]]></category>
		<category><![CDATA[web browser]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=232</guid>
		<description><![CDATA[Hemispherx BioPharma Inc.
(Public, AMEX:HEB)
At approximately 3:30pm EST, 5/29/09, StocksHaven Investments began the call conference scheduled with Chairman #38; CEO of Hemispherx BioPharma Inc., Dr. William Carter. The basis interview was with regards to TheStreet.com#8217;s Adam Feuerstein#8217;s recent article, #8220;Hemispherx#8217;s CFS Drug Is a Long Shot#8220;.  The interview was concluded as of 4:00pm EST, 5/29/09. Many [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/conference-call-hemispherx-responds-to-thestreetcom/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Hemispherx Fights Back Against Feuerstein</title>
		<link>http://www.straightstocks.com/stock-watch/hemispherx-fights-back-against-feuerstein/</link>
		<comments>http://www.straightstocks.com/stock-watch/hemispherx-fights-back-against-feuerstein/#comments</comments>
		<pubDate>Fri, 29 May 2009 12:40:12 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing]]></category>
		<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Videos]]></category>
		<category><![CDATA[Adam]]></category>
		<category><![CDATA[Adam Feuerstein;]]></category>
		<category><![CDATA[Adam Feurerstein;]]></category>
		<category><![CDATA[Agency on Health Research Quality;]]></category>
		<category><![CDATA[Alferon;]]></category>
		<category><![CDATA[America]]></category>
		<category><![CDATA[Ampligen;]]></category>
		<category><![CDATA[Asia]]></category>
		<category><![CDATA[Avian Influenza;]]></category>
		<category><![CDATA[Biotech Select;]]></category>
		<category><![CDATA[blister]]></category>
		<category><![CDATA[Chronic Fatigue Syndrome Advisory Committee;]]></category>
		<category><![CDATA[chronic fatigue syndrome;]]></category>
		<category><![CDATA[D.C.]]></category>
		<category><![CDATA[Department of Health and Human Services;]]></category>
		<category><![CDATA[Emory University]]></category>
		<category><![CDATA[energy]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Food And Drug Administration]]></category>
		<category><![CDATA[Food Chain]]></category>
		<category><![CDATA[Forbes Magazine]]></category>
		<category><![CDATA[H1N1 virus;]]></category>
		<category><![CDATA[Health Insurance]]></category>
		<category><![CDATA[heart failure]]></category>
		<category><![CDATA[Hemispherx Biopharma;]]></category>
		<category><![CDATA[homeostatic systems;]]></category>
		<category><![CDATA[Influenza]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[Japanese Government]]></category>
		<category><![CDATA[Japanese military;]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[National Institute of Health]]></category>
		<category><![CDATA[Obama administration]]></category>
		<category><![CDATA[Pharmaceutical]]></category>
		<category><![CDATA[Pharmaceutical Industry]]></category>
		<category><![CDATA[snake oil;]]></category>
		<category><![CDATA[social media sites;]]></category>
		<category><![CDATA[Social Security Administration]]></category>
		<category><![CDATA[Speculative Play - Biogen Idec Inc;]]></category>
		<category><![CDATA[streaming video]]></category>
		<category><![CDATA[Swine Flu;]]></category>
		<category><![CDATA[television networks]]></category>
		<category><![CDATA[U.S. Centers for Disease Control and Prevention;]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Vaccines]]></category>
		<category><![CDATA[Washington]]></category>
		<category><![CDATA[William A. Carter;]]></category>
		<category><![CDATA[William Reeves;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=231</guid>
		<description><![CDATA[In the latest developments of Hemispherx BioPharma, BioMedReports analyzes and dissects the latest article from TheStreet.com with an interview involving Dr. Carter. If you are an avid fan of Ampligen and have invested in Hemispherx, this read is definitely worth your time.

Article published by M.E. Garza of BioMedReports.com
“What do we think CFS is?” Dr. William [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/hemispherx-fights-back-against-feuerstein/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Company Review &#8211; GearZap.com</title>
		<link>http://www.straightstocks.com/stock-watch/company-review-gearzapcom/</link>
		<comments>http://www.straightstocks.com/stock-watch/company-review-gearzapcom/#comments</comments>
		<pubDate>Thu, 28 May 2009 15:01:09 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[cluttering;]]></category>
		<category><![CDATA[Day Trader]]></category>
		<category><![CDATA[Extreme FDA Trade;]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[specialist online retailer;]]></category>
		<category><![CDATA[StocksHaven Investments;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=230</guid>
		<description><![CDATA[Occasionally here at StocksHaven Investments we will review company websites that in some way fit in with the daily life of an investor. Laptops are seen as an essential tool to any day trader#8217;s lifestyle, so this company was deemed a perfect fit for our next review.


Design - The design is mostly grey on white [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/company-review-gearzapcom/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Tips for a Stellar Conference Call</title>
		<link>http://www.straightstocks.com/stock-watch/tips-for-a-stellar-conference-call/</link>
		<comments>http://www.straightstocks.com/stock-watch/tips-for-a-stellar-conference-call/#comments</comments>
		<pubDate>Tue, 26 May 2009 04:41:58 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Call Conference - Hemispherx BioPharma Inc;]]></category>
		<category><![CDATA[DON TS;]]></category>
		<category><![CDATA[Elaine ;]]></category>
		<category><![CDATA[Joe]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[paging;]]></category>
		<category><![CDATA[StocksHaven Investments;]]></category>
		<category><![CDATA[value tool;]]></category>
		<category><![CDATA[video conferencing]]></category>
		<category><![CDATA[Web-based conferencing]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=229</guid>
		<description><![CDATA[Many private investors have graciously given positive reviews for StocksHaven Investments#8217; latest conference call with emispherx BioPharma (Public, AMEX:HEB). Due to this, a follow up list providing essentials and guidance for successful conference calls seemed like a great idea. So without further adue, here is Michael Vlaicu#8217;s strategies on championing this task:  
1. [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/tips-for-a-stellar-conference-call/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cost of Living Plagues Retirement Plans</title>
		<link>http://www.straightstocks.com/stock-watch/cost-of-living-plagues-retirement-plans/</link>
		<comments>http://www.straightstocks.com/stock-watch/cost-of-living-plagues-retirement-plans/#comments</comments>
		<pubDate>Thu, 21 May 2009 02:36:54 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Electricity]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[food]]></category>
		<category><![CDATA[Institute of Fiscal Studies;]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=227</guid>
		<description><![CDATA[Ready to retire? Not so fast.
There was a time when people looked forward to their retirement, but it is now a time of dread for many senior citizens. Whilst mortgage and rental costs are often lower for seniors, the cost of gas, electricity, lighting and food actually goes up. In January 2009 The Institute of Fiscal Studies calculated that [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/cost-of-living-plagues-retirement-plans/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Barack Obama Spoof &#8211; Blame It</title>
		<link>http://www.straightstocks.com/stock-watch/barack-obama-spoof-blame-it/</link>
		<comments>http://www.straightstocks.com/stock-watch/barack-obama-spoof-blame-it/#comments</comments>
		<pubDate>Wed, 20 May 2009 21:13:03 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Videos]]></category>
		<category><![CDATA[Barack Obama Spoof;]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=226</guid>
		<description><![CDATA[Because we all deserve a good laugh after a long days worth of work.

Random Posts

7 Essential Tips for Young Investors
Are you feeling the sugar high yet?
4 Secrets to Successful Investing
Struggling Families Seek Pawnbrokers for Salvation]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/barack-obama-spoof-blame-it/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Call Conference &#8211; Hemispherx BioPharma Inc.</title>
		<link>http://www.straightstocks.com/stock-watch/call-conference-hemispherx-biopharma-inc/</link>
		<comments>http://www.straightstocks.com/stock-watch/call-conference-hemispherx-biopharma-inc/#comments</comments>
		<pubDate>Fri, 15 May 2009 22:13:50 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Call Conference - Hemispherx BioPharma Inc;]]></category>
		<category><![CDATA[Carter]]></category>
		<category><![CDATA[Hemispherx Biopharma Inc.;]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[StocksHaven Investments;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=112</guid>
		<description><![CDATA[Hemispherx BioPharma Inc.
(Public, AMEX:HEB)
At approximately 4:30pm EST, 5/15/09, StocksHaven Investments began the call conference scheduled with Chairman #38; CEO of Hemispherx BioPharma Inc., Dr. William Carter. The interview process was a tremendous success and was concluded as of 5:00pm EST, 5/15/09. Many issues and concerns of private individual investors were raised and answered in a [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/call-conference-hemispherx-biopharma-inc/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>PGYC Receives Buyout of $0.57 Per Share</title>
		<link>http://www.straightstocks.com/stock-watch/pgyc-receives-buyout-of-057-per-share/</link>
		<comments>http://www.straightstocks.com/stock-watch/pgyc-receives-buyout-of-057-per-share/#comments</comments>
		<pubDate>Fri, 15 May 2009 13:42:13 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing]]></category>
		<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Videos]]></category>
		<category><![CDATA[Marmara;]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Oil And Gas Exploration]]></category>
		<category><![CDATA[oil and gas industry]]></category>
		<category><![CDATA[oil and gas reserves]]></category>
		<category><![CDATA[Patriot Energy Corp.]]></category>
		<category><![CDATA[stock market analysis tools;]]></category>
		<category><![CDATA[Tatham Offshore Inc.;]]></category>
		<category><![CDATA[Toshent;]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=111</guid>
		<description><![CDATA[Patriot Energy Corp.
(Public, OTC:PGYC)
About: Patriot Energy Corp., formerly Tatham Offshore Inc., has provided offshore contract drilling services to the oil and gas industry in the Gulf and Atlantic Canada. The Company had been engaged in the development, exploration and production of oil and gas reserves located primarily in the Gulf focusing principally on the flextrend [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/pgyc-receives-buyout-of-057-per-share/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Acadia Pharmaceuticals’ Cash Infusion May Help Parkinson’s Patients</title>
		<link>http://www.straightstocks.com/stock-watch/acadia-pharmaceuticals%e2%80%99-cash-infusion-may-help-parkinson%e2%80%99s-patients/</link>
		<comments>http://www.straightstocks.com/stock-watch/acadia-pharmaceuticals%e2%80%99-cash-infusion-may-help-parkinson%e2%80%99s-patients/#comments</comments>
		<pubDate>Thu, 14 May 2009 14:08:29 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Acadia Pharmaceuticals Inc.;]]></category>
		<category><![CDATA[Allergan]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[biotechnology stocks;]]></category>
		<category><![CDATA[Biovail Corp]]></category>
		<category><![CDATA[central nervous system disorders]]></category>
		<category><![CDATA[Diego drug;]]></category>
		<category><![CDATA[Drug Discovery]]></category>
		<category><![CDATA[Jason Napodano]]></category>
		<category><![CDATA[Kay Mixson Jenkins;]]></category>
		<category><![CDATA[Meiji Seika Kaisha Ltd;]]></category>
		<category><![CDATA[Michael J. Fox Foundation;]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Pharmaceutical]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[schizophrenia]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=110</guid>
		<description><![CDATA[Acadia Pharmaceuticals, Inc.
(Public, NASDAQ:ACAD)
A San Diego drug maker is hoping an infusion of research capital will allow it to continue its work in searching for Parkinson#8217;s disease treatments.
Acadia Pharmaceuticals (NASDAQ:ACAD)‎, which hopes its drug, pimavanserin, will treat Parkinson#8217;s-related psychosis, recently received $30 million from Canadian pharmaceuticals company Biovail Corp. (NYSE: BVF) in a deal that [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/acadia-pharmaceuticals%e2%80%99-cash-infusion-may-help-parkinson%e2%80%99s-patients/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Comments and Suggestions Regarding Hemispherx’s Conference</title>
		<link>http://www.straightstocks.com/stock-watch/comments-and-suggestions-regarding-hemispherx%e2%80%99s-conference/</link>
		<comments>http://www.straightstocks.com/stock-watch/comments-and-suggestions-regarding-hemispherx%e2%80%99s-conference/#comments</comments>
		<pubDate>Thu, 14 May 2009 00:04:58 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Hemispherx Pharmaceuticals Inc.;]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Spock;]]></category>
		<category><![CDATA[SS Enterprise;]]></category>
		<category><![CDATA[StocksHaven Investments;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=109</guid>
		<description><![CDATA[At this time StocksHaven Investments would like to open and establish the option of submitting your questions, comments and requests you would like to be forward while engaged within the Hemispherx Pharmaceuticals, Inc. voice conference which is scheduled on May/13/09. Please use the #8216;Contant Us#8216; tab located in the menu bar.
Any racial, discriminatory, sexually offensive [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/comments-and-suggestions-regarding-hemispherx%e2%80%99s-conference/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Business Conferences &#8211; ACUS, HEB</title>
		<link>http://www.straightstocks.com/stock-watch/business-conferences-acus-heb/</link>
		<comments>http://www.straightstocks.com/stock-watch/business-conferences-acus-heb/#comments</comments>
		<pubDate>Wed, 13 May 2009 03:29:37 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[chronic fatigue syndrome;]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Hemixpherx Biopharma Inc.;]]></category>
		<category><![CDATA[HIV]]></category>
		<category><![CDATA[HPV;]]></category>
		<category><![CDATA[Java]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Oragens;]]></category>
		<category><![CDATA[StocksHaven Investments;]]></category>
		<category><![CDATA[treatment for chronic fatigue syndrome;]]></category>
		<category><![CDATA[viral diseases;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=108</guid>
		<description><![CDATA[Today I have some exciting news to share with you all. Due to the influx of emails I have been receiving lately on inquiries regarding the latest FDA deadlines on (Public, AMEX:HEB) and (Public, OTC:ACUS), StocksHaven Investments alongside BioMedReports.com will be hosting video and phone conferences with their investor relation spokespersons. Rest assured the conversations [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/business-conferences-acus-heb/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Extreme FDA Trade &#8211; ABIO</title>
		<link>http://www.straightstocks.com/stock-watch/extreme-fda-trade-abio/</link>
		<comments>http://www.straightstocks.com/stock-watch/extreme-fda-trade-abio/#comments</comments>
		<pubDate>Mon, 11 May 2009 14:34:47 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[ARCA Biopharma Inc]]></category>
		<category><![CDATA[Biopharmaceutical]]></category>
		<category><![CDATA[cardiovascular diseases]]></category>
		<category><![CDATA[Extreme FDA Trade;]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Gencaro;]]></category>
		<category><![CDATA[heart failure]]></category>
		<category><![CDATA[Labcorp]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[New York Heart Association;]]></category>
		<category><![CDATA[Nuvelo Inc.]]></category>
		<category><![CDATA[stock market analysis tools;]]></category>
		<category><![CDATA[therapies for heart failure]]></category>
		<category><![CDATA[treatment of chronic heart failure]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[United States Food and Drug Administration]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=107</guid>
		<description><![CDATA[ARCA Biopharma, Inc.
(Public, NASDAQ:ABIO)
Heart failure has always been one of the predominant fatal human conditions, therefore this week I will be focusing on a company which has developed a highly successful treatment.
The broad world market for this drug is truly spectacular.

Key Facts: Heart failure becomes more common with increasing age. About 1 in 35 people [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/extreme-fda-trade-abio/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Investment Tips From The Oracle</title>
		<link>http://www.straightstocks.com/stock-watch/investment-tips-from-the-oracle/</link>
		<comments>http://www.straightstocks.com/stock-watch/investment-tips-from-the-oracle/#comments</comments>
		<pubDate>Sun, 10 May 2009 06:51:55 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Berkshire Hathaway]]></category>
		<category><![CDATA[Charlie Munger;]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Oracle]]></category>
		<category><![CDATA[personal-finance]]></category>
		<category><![CDATA[Warren Buffet]]></category>
		<category><![CDATA[Warren Buffett]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=105</guid>
		<description><![CDATA[As we all take steps which lead us closer to our investment dreams, I believe there is no greater source of knowledge than from the master financial mogul himself, Warren Buffet. He alone is the reason investing became my life, and I feel it is very important to engrave his teachings to solidify your stock [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/investment-tips-from-the-oracle/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA Watchlist &#8211; ACUS</title>
		<link>http://www.straightstocks.com/stock-watch/fda-watchlist-acus/</link>
		<comments>http://www.straightstocks.com/stock-watch/fda-watchlist-acus/#comments</comments>
		<pubDate>Sat, 09 May 2009 13:34:33 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Acusphere Inc.;]]></category>
		<category><![CDATA[American Heart Association;]]></category>
		<category><![CDATA[CAD]]></category>
		<category><![CDATA[cardiac imaging agent;]]></category>
		<category><![CDATA[coronary artery disease]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Heart Attack]]></category>
		<category><![CDATA[Heart Disease]]></category>
		<category><![CDATA[heart failure]]></category>
		<category><![CDATA[Imagify;]]></category>
		<category><![CDATA[Injectable;]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[perflubutane gas;]]></category>
		<category><![CDATA[perfusion imaging agent;]]></category>
		<category><![CDATA[Pharmaceutical]]></category>
		<category><![CDATA[pharmacologic products;]]></category>
		<category><![CDATA[porous microparticle technology;]]></category>
		<category><![CDATA[post-processing;]]></category>
		<category><![CDATA[StocksHaven Investments;]]></category>
		<category><![CDATA[treatment of chronic heart failure]]></category>
		<category><![CDATA[ultrasound]]></category>
		<category><![CDATA[ultrasound imaging agent;]]></category>
		<category><![CDATA[ultrasound imaging procedure using ultrasound;]]></category>
		<category><![CDATA[United States]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=104</guid>
		<description><![CDATA[Acusphere, Inc.
(Public, OTC:ACUS)
Continuing the FDA journey to riches, I have chosen ACUS as my next prime target. I see alot of benefit and potential in this company, not only from its currently cheap PPS, but also from the vast potential market. The time is now to load up on this company (if you haven#8217;t already [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/fda-watchlist-acus/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA Watchlist &#8211; HEB</title>
		<link>http://www.straightstocks.com/stock-watch/fda-watchlist-heb/</link>
		<comments>http://www.straightstocks.com/stock-watch/fda-watchlist-heb/#comments</comments>
		<pubDate>Fri, 08 May 2009 13:12:35 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Alferon N;]]></category>
		<category><![CDATA[Ampligen;]]></category>
		<category><![CDATA[Biopharmaceutical]]></category>
		<category><![CDATA[C12U;]]></category>
		<category><![CDATA[chronic fatigue syndrome;]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Hemispherx Biopharma Inc.;]]></category>
		<category><![CDATA[Influenza]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[natural immune system enhancing technologies;]]></category>
		<category><![CDATA[treatment for chronic fatigue syndrome;]]></category>
		<category><![CDATA[treatment of viral and immune based chronic disorders;]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[viral diseases;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=103</guid>
		<description><![CDATA[Due to the explosive demand for BioPharma companies pending Food and Drug Approval on new and innovative drugs, I will begin focusing on companies which are a few weeks away from their reviews. Taking notice of the recent 3000%, and 1000% over night gains respectively of TTNP and VNDA, the risk versus rewards leans well [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/fda-watchlist-heb/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Bear Market Armageddon</title>
		<link>http://www.straightstocks.com/stock-watch/bear-market-armageddon/</link>
		<comments>http://www.straightstocks.com/stock-watch/bear-market-armageddon/#comments</comments>
		<pubDate>Thu, 07 May 2009 15:23:26 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Bank]]></category>
		<category><![CDATA[Bank Of America]]></category>
		<category><![CDATA[bank-stress-test results;]]></category>
		<category><![CDATA[China Construction Bank]]></category>
		<category><![CDATA[Citigroup]]></category>
		<category><![CDATA[Columbia Management;]]></category>
		<category><![CDATA[Fdic]]></category>
		<category><![CDATA[Federal Deposit Insurance Corp]]></category>
		<category><![CDATA[Financial Enhancement Group;]]></category>
		<category><![CDATA[Fixed Income Products]]></category>
		<category><![CDATA[Joe Clark]]></category>
		<category><![CDATA[Joshua Siegel;]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[MIT]]></category>
		<category><![CDATA[Morgan Stanley]]></category>
		<category><![CDATA[retail banking divisions;]]></category>
		<category><![CDATA[School of Management;]]></category>
		<category><![CDATA[senate banking committee]]></category>
		<category><![CDATA[Sheila Bair]]></category>
		<category><![CDATA[Simon Johnson]]></category>
		<category><![CDATA[StoneCastle Partners;]]></category>
		<category><![CDATA[Timothy  Geithner;]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[wall street]]></category>
		<category><![CDATA[Washington]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=102</guid>
		<description><![CDATA[I am urging you all to buy (Public, NYSE:FAZ) yet again at these low levels. The bears are coming out hungry, and are set to have an all-you-can-dine feast on these financial crooks.
Read this article I stumbled upon, it proves even Forbes believes these stress tests are simply a distraction.
The worst-kept secret in Washington and [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/bear-market-armageddon/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>An Everlasting Milestone &#8211; Thank You</title>
		<link>http://www.straightstocks.com/stock-watch/an-everlasting-milestone-thank-you/</link>
		<comments>http://www.straightstocks.com/stock-watch/an-everlasting-milestone-thank-you/#comments</comments>
		<pubDate>Wed, 06 May 2009 03:44:41 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Online Investments Mogul;]]></category>
		<category><![CDATA[StocksHaven Investments;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=101</guid>
		<description><![CDATA[Today is a very special day for me; One which embarks both a fresh start, as well as a new journey in my life. The first few steps to achieving the cornerstones which I have set for myself since I have taken my first few steps becoming a true Online Investments Mogul.
This website is now [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/an-everlasting-milestone-thank-you/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Daily Bargains &#8211; May/5/09 &#8211; QTWW  FAZ</title>
		<link>http://www.straightstocks.com/stock-watch/daily-bargains-may509-qtww-faz/</link>
		<comments>http://www.straightstocks.com/stock-watch/daily-bargains-may509-qtww-faz/#comments</comments>
		<pubDate>Tue, 05 May 2009 17:51:11 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Alan Niedzwiecki]]></category>
		<category><![CDATA[alternative fuel technologies]]></category>
		<category><![CDATA[Bank Stocks]]></category>
		<category><![CDATA[bank-stress-test results;]]></category>
		<category><![CDATA[energy]]></category>
		<category><![CDATA[Energy Storage Technologies]]></category>
		<category><![CDATA[FAZ 
Direxion Daily;]]></category>
		<category><![CDATA[fuel cell]]></category>
		<category><![CDATA[fuel technologies]]></category>
		<category><![CDATA[hybrid electric drive systems;]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[propulsion systems]]></category>
		<category><![CDATA[Quantum Fuel Systems Technologies Worldwide Inc]]></category>
		<category><![CDATA[Quantum Fuel Systems Technologies;]]></category>
		<category><![CDATA[Traded Fund;]]></category>
		<category><![CDATA[United States Army]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Volvo]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=100</guid>
		<description><![CDATA[Today I have two smart plays for the short-term:
Quantum Fuel Systems Technologies
(Public, NASDAQ:QTWW)
Today the market is flourishing, rising high and the prices seem way over inflated. However, amongst these green giants I see potential in QTWW which has fallen by over 10% today. Based on favourable charts, this is a good buy today for a [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/daily-bargains-may509-qtww-faz/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Reiterating Buy On MESA</title>
		<link>http://www.straightstocks.com/stock-watch/reiterating-buy-on-mesa/</link>
		<comments>http://www.straightstocks.com/stock-watch/reiterating-buy-on-mesa/#comments</comments>
		<pubDate>Fri, 01 May 2009 14:49:15 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Videos]]></category>
		<category><![CDATA[Airline]]></category>
		<category><![CDATA[Mesa Air Group Inc.;]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Speculative Play - Biogen Idec Inc;]]></category>
		<category><![CDATA[Swine Flu;]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=99</guid>
		<description><![CDATA[Mesa Air Group, Inc.
MESA is a strong BUY @ $0.178
It#8217;s very easy to see how (Public, NASDAQ:MESA) is highly undervalued at its current PPS. At the moment all worldwide airline companies have dropped significantly in price due to the progressive fear of Swine Flu. Regular customers cancelling tickets, missed vacations and family gatherings #8212; It [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/reiterating-buy-on-mesa/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Struggling Families Seek Pawnbrokers for Salvation</title>
		<link>http://www.straightstocks.com/stock-watch/struggling-families-seek-pawnbrokers-for-salvation/</link>
		<comments>http://www.straightstocks.com/stock-watch/struggling-families-seek-pawnbrokers-for-salvation/#comments</comments>
		<pubDate>Thu, 30 Apr 2009 17:03:41 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[bank card;]]></category>
		<category><![CDATA[Cash Converters International Limited;]]></category>
		<category><![CDATA[credit card
 applications;]]></category>
		<category><![CDATA[eBay Inc.]]></category>
		<category><![CDATA[Gbp]]></category>
		<category><![CDATA[H&T Group;]]></category>
		<category><![CDATA[Mesa Air Group;]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[online phenomenon;]]></category>
		<category><![CDATA[Speculative Play - Biogen Idec Inc;]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=98</guid>
		<description><![CDATA[At a time not too long ago, pawn shops seemed like an ideal place to discharge unwanted items for a small amount; Something to give you that little extra cash in your wallet. Of course with the emergence of the Internet, the concept of a pawn shop has taken a new meaning through eBay (Public, [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/struggling-families-seek-pawnbrokers-for-salvation/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Antigenics is a buy &#8211; Brain Tumour FDA</title>
		<link>http://www.straightstocks.com/stock-watch/antigenics-is-a-buy-brain-tumour-fda/</link>
		<comments>http://www.straightstocks.com/stock-watch/antigenics-is-a-buy-brain-tumour-fda/#comments</comments>
		<pubDate>Wed, 29 Apr 2009 13:44:27 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Andrew T. Parsa;]]></category>
		<category><![CDATA[Antigenics Inc.]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Brain Cancer]]></category>
		<category><![CDATA[brain tumor]]></category>
		<category><![CDATA[Brain Tumors;]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Cancers]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Glioma;]]></category>
		<category><![CDATA[head traumas;]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[National Cancer Institute]]></category>
		<category><![CDATA[San Francisco]]></category>
		<category><![CDATA[treatment of glioma (brain cancer;]]></category>
		<category><![CDATA[U.S. Food and Drug Administration]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[University of California]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=96</guid>
		<description><![CDATA[Antigenics, Inc.
(Public, NASDAQ:AGEN) is a buy
About: Antigenics Inc. (Antigenics), is a biotechnology company focused on developing and commercializing technologies to treat cancers and infectious diseases, primarily based on immunological approaches.
News Headlines: 
Antigenics, Inc. Gets FDA Approval For Orphan Drug Designation To Oncophage For Treatment Of Glioma
Antigenics, Inc. announced that Oncophage (vitespen) has been granted orphan [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/antigenics-is-a-buy-brain-tumour-fda/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Urgent Swine Flu Alert &#8211; LWLLE</title>
		<link>http://www.straightstocks.com/stock-watch/urgent-swine-flu-alert-lwlle/</link>
		<comments>http://www.straightstocks.com/stock-watch/urgent-swine-flu-alert-lwlle/#comments</comments>
		<pubDate>Mon, 27 Apr 2009 14:36:36 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Linkwell Corporation]]></category>
		<category><![CDATA[LWLLE;]]></category>
		<category><![CDATA[Mexico]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Swine Flu infection;]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Vaccines]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=95</guid>
		<description><![CDATA[Linkwell Corporation
 (Public, OTC:LWLLE) is a buy @ $0.14
Swine Flu plays will likely explode this week like nothing you have ever seen before. However, while there are dozens of companies working on vaccines#8230; these vaccines could take years to develop and most of these companies will be failures. Not to mention they are the number [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/urgent-swine-flu-alert-lwlle/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Mysterious Case of Credit Card Enslavement</title>
		<link>http://www.straightstocks.com/market-commentary/the-mysterious-case-of-credit-card-enslavement/</link>
		<comments>http://www.straightstocks.com/market-commentary/the-mysterious-case-of-credit-card-enslavement/#comments</comments>
		<pubDate>Sat, 25 Apr 2009 12:33:28 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[America]]></category>
		<category><![CDATA[Credit Card Debt]]></category>
		<category><![CDATA[Credit Cards]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Gbp]]></category>
		<category><![CDATA[hotel chains;]]></category>
		<category><![CDATA[Oil]]></category>
		<category><![CDATA[United Kingdom]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[uSwitch.com;]]></category>

		<guid isPermaLink="false">http://www.straightstocks.com/market-commentary/the-mysterious-case-of-credit-card-enslavement/</guid>
		<description><![CDATA[Ah…yes, the mighty credit card. I still remember being that teenage kid when I  first received one in the mail – what a joyful day that was. Told myself, “I’m  worth ten thousand dollars now”! If only I knew the irony behind that  afterthought years later. So then ladies and gentlemen, let’s [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/market-commentary/the-mysterious-case-of-credit-card-enslavement/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Mesa Air Group &#8211; Speculative Play</title>
		<link>http://www.straightstocks.com/stock-watch/mesa-air-group-speculative-play/</link>
		<comments>http://www.straightstocks.com/stock-watch/mesa-air-group-speculative-play/#comments</comments>
		<pubDate>Fri, 24 Apr 2009 18:07:42 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Airline]]></category>
		<category><![CDATA[Airline Industry]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[District Of Columbia]]></category>
		<category><![CDATA[interisland carrier;]]></category>
		<category><![CDATA[Mesa Air Group Inc.;]]></category>
		<category><![CDATA[Mexico]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Phoenix]]></category>
		<category><![CDATA[the Bahamas]]></category>
		<category><![CDATA[Traffic]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=94</guid>
		<description><![CDATA[Mesa Air Group, Inc.
MESA is a buy @ $0.195
About: Mesa Air Group, Inc. (Mesa) is a holding company whose principal subsidiaries operate as regional air carriers providing scheduled passenger and airfreight service. As of September 30, 2007, the Company served 184 cities in 45 states, the District of Columbia, Canada, the Bahamas and Mexico and [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/mesa-air-group-speculative-play/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>$50 in Free Trades for New Sign ups: Questrade Coupon</title>
		<link>http://www.straightstocks.com/stock-watch/50-in-free-trades-for-new-sign-ups-questrade-coupon/</link>
		<comments>http://www.straightstocks.com/stock-watch/50-in-free-trades-for-new-sign-ups-questrade-coupon/#comments</comments>
		<pubDate>Fri, 24 Apr 2009 16:39:00 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Affiliate]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[cheapest online discount brokers;]]></category>
		<category><![CDATA[Questrade;]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Warren Buffet]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=41</guid>
		<description><![CDATA[So I have recently just made a deal with Questrade, one of the cheapest online discount brokers around. So let me cut right to the chase#8230;

Only $4.95 per trade
No monthly fees!
Min. balance of only $1000
Top notch customer care (phone call takes no more than 2 minutes to be answered)



Update: Questrade now offers the lowest cost [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/50-in-free-trades-for-new-sign-ups-questrade-coupon/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Penny Stocks Watchlist &#8211; April 24/09</title>
		<link>http://www.straightstocks.com/stock-watch/penny-stocks-watchlist-april-2409/</link>
		<comments>http://www.straightstocks.com/stock-watch/penny-stocks-watchlist-april-2409/#comments</comments>
		<pubDate>Thu, 23 Apr 2009 05:40:08 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Dayton Superior Corporation;]]></category>
		<category><![CDATA[Delaware]]></category>
		<category><![CDATA[EF Johnson Technologies Inc;]]></category>
		<category><![CDATA[ES Series Portable Radio;]]></category>
		<category><![CDATA[Fdic]]></category>
		<category><![CDATA[GE Capital]]></category>
		<category><![CDATA[GPS]]></category>
		<category><![CDATA[Indiana]]></category>
		<category><![CDATA[Mesa Air Group;]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[Microphone;]]></category>
		<category><![CDATA[pence]]></category>
		<category><![CDATA[products]]></category>
		<category><![CDATA[Series Mobile Radio;]]></category>
		<category><![CDATA[U.S. Bankruptcy  Court]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=93</guid>
		<description><![CDATA[Here is a list of 2 Penny Stock Companies which are both Nasdaq listed and contain highly favourable chart patterns - bottomed out with uptrend behaviours on the graphs, along with great PRs. Take a look#8230;
EF Johnson Technologies, Inc.
(Public, NASDAQ:EFJI) - Today announced that it will highlight its award-winning ES Series of Project 25 radios [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/penny-stocks-watchlist-april-2409/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Drowning in the Ocean of Debt</title>
		<link>http://www.straightstocks.com/stock-watch/drowning-in-the-ocean-of-debt/</link>
		<comments>http://www.straightstocks.com/stock-watch/drowning-in-the-ocean-of-debt/#comments</comments>
		<pubDate>Tue, 14 Apr 2009 20:59:12 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Videos]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=88</guid>
		<description><![CDATA[Related Posts

The Mysterious Case of Credit Card Enslavement]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/drowning-in-the-ocean-of-debt/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>EESO is a buy &#8211; Pick of the Year</title>
		<link>http://www.straightstocks.com/stock-watch/eeso-is-a-buy-pick-of-the-year/</link>
		<comments>http://www.straightstocks.com/stock-watch/eeso-is-a-buy-pick-of-the-year/#comments</comments>
		<pubDate>Mon, 13 Apr 2009 17:44:55 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Enzyme Environmental Solutions Inc;]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[odor remediation applications;]]></category>
		<category><![CDATA[Oil]]></category>
		<category><![CDATA[purpose products;]]></category>
		<category><![CDATA[retail]]></category>
		<category><![CDATA[south korea]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[water treatment solutions;]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=86</guid>
		<description><![CDATA[Enzyme Environmental Solutions, Inc.
(Public, OTC:EESO) is a buy @ 0.0195
I am announcing that this will be my stock pick of the year. Colossal upside potential not only from its product, but also buyout opportunities!
About: Enzyme Environmental Solutions, Incorporated (EESI) produces an enzyme solution used in a variety of special purpose products. The Company manufactures the [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/eeso-is-a-buy-pick-of-the-year/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Company Watchlist &#8211; April 13-17/09</title>
		<link>http://www.straightstocks.com/stock-watch/company-watchlist-april-13-1709/</link>
		<comments>http://www.straightstocks.com/stock-watch/company-watchlist-april-13-1709/#comments</comments>
		<pubDate>Sat, 11 Apr 2009 23:34:29 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[America]]></category>
		<category><![CDATA[bank balances;]]></category>
		<category><![CDATA[Flash Memory]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[memory solutions]]></category>
		<category><![CDATA[Mesa Air Group;]]></category>
		<category><![CDATA[Raju;]]></category>
		<category><![CDATA[rupee]]></category>
		<category><![CDATA[Samsung]]></category>
		<category><![CDATA[semiconductor]]></category>
		<category><![CDATA[Sony]]></category>
		<category><![CDATA[Spansion Inc.;]]></category>
		<category><![CDATA[SpongeTech Delivery Systems Inc]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=85</guid>
		<description><![CDATA[This coming Monday should turn out to be one of the most interesting opening bell#8217;s as of late. A Lot of buyout rumours, Q10s being reported and amongst other things, we should get a more clear picture as to the progression of the US banking system.
Some of the companies I will be keeping a [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/company-watchlist-april-13-1709/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
